Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Patrick Walsh

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Prostatectomy

Chemicals & Drugs

Anatomy

Concepts & Ideas

Physiology

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Loeb Stacy; Kettermann Anna; Carter H Ballentine; Ferrucci Luigi; Metter E Jeffrey; Walsh Patrick C
Prostate volume changes over time: results from the Baltimore Longitudinal Study of Aging.
Kader A Karim; Sun Jielin; Isaacs Sarah D; Wiley Kathleen E; Yan Guifang; Kim Seong-Tae; Fedor Helen; DeMarzo Angelo M; Epstein Jonathan I; Walsh Patrick C; Partin Alan W; Trock Bruce; Zheng S Lilly; Xu Jianfeng; Isaacs William
Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients.
Lu Lingyi; Sun Jielin; Isaacs Sarah D; Wiley Kathleen E; Smith Shelly; Pruett Kristen; Zhu Yi; Zhang Zheng; Wiklund Fredrik; Grönberg Henrik; Walsh Patrick C; Chang Bao-Li; Zheng S Lilly; Isaacs William B; Xu Jianfeng
Fine-mapping and family-based association analyses of prostate cancer risk variants at Xp11.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Patrick Walsh (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Loeb Stacy; Kettermann Anna; Carter H Ballentine; Ferrucci Luigi; Metter E Jeffrey; Walsh Patrick C
Prostate volume changes over time: results from the Baltimore Longitudinal Study of Aging.
The Journal of urology 2009;182(4):1458-62.
2009: Kader A Karim; Sun Jielin; Isaacs Sarah D; Wiley Kathleen E; Yan Guifang; Kim Seong-Tae; Fedor Helen; DeMarzo Angelo M; Epstein Jonathan I; Walsh Patrick C; Partin Alan W; Trock Bruce; Zheng S Lilly; Xu Jianfeng; Isaacs William
Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients.
The Prostate 2009;69(11):1195-205.
2009: Lu Lingyi; Sun Jielin; Isaacs Sarah D; Wiley Kathleen E; Smith Shelly; Pruett Kristen; Zhu Yi; Zhang Zheng; Wiklund Fredrik; Grönberg Henrik; Walsh Patrick C; Chang Bao-Li; Zheng S Lilly; Isaacs William B; Xu Jianfeng
Fine-mapping and family-based association analyses of prostate cancer risk variants at Xp11.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(7):2132-6.
2009: Xu Jianfeng; Kibel Adam S; Hu Jennifer J; Turner Aubrey R; Pruett Kristen; Zheng Siqun Lilly; Sun Jielin; Isaacs Sarah D; Wiley Kathleen E; Kim Seong-Tae; Hsu Fang-Chi; Wu William; Torti Frank M; Walsh Patrick C; Chang Bao-Li; Isaacs William B
Prostate cancer risk associated loci in African Americans.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(7):2145-9.
2009: Loeb Stacy; Carter H Ballentine; Walsh Patrick C; Isaacs William B; Kettermann Anna; Tanaka Toshiko; Ferrucci Luigi; Metter E Jeffrey
Single nucleotide polymorphisms and the likelihood of prostate cancer at a given prostate specific antigen level.
The Journal of urology 2009;182(1):101-4; discussion 105.
2009: Walsh Patrick C
2008 Whitmore Lecture: Radical prostatectomy--where we were and where we are going.
Urologic oncology 2009;27(3):246-50.
2009: Loeb Stacy; Schaeffer Edward M; Chan Daniel W; Carter H Ballentine; Walsh Patrick C; Sokoll Lori J
Investigation of human anti-mouse antibodies as potential cause of postprostatectomy PSA elevation.
Urology 2009;73(5):947-9.
2009: Hsu Fang-Chi; Sun Jielin; Wiklund Fredrik; Isaacs Sarah D; Wiley Kathleen E; Purcell Lina D; Gao Zhengrong; Stattin Pär; Zhu Yi; Kim Seong-Tae; Zhang Zheng; Liu Wennuan; Chang Bao-Li; Walsh Patrick C; Duggan David; Carpten John D; Isaacs William B; Grönberg Henrik; Xu Jianfeng; Zheng S Lilly
A novel prostate cancer susceptibility locus at 19q13.
Cancer research 2009;69(7):2720-3.
2009: Walsh Patrick C
Re: It's time to abandon an upper limit of normal for prostate specific antigen: assessing the risk of prostate cancer: I. M. Thompson, D. P. Ankerst, R. Etzioni and T. Wang J Urol 2008; 180: 1219-1222.
The Journal of urology 2009;181(3):1499; author reply 1499-500.
2008: Nielsen Matthew E; Schaeffer Edward M; Marschke Penny; Walsh Patrick C
High anterior release of the levator fascia improves sexual function following open radical retropubic prostatectomy.
The Journal of urology 2008;180(6):2557-64; discussion 2564.
2008: Walsh Patrick C
Perfecting nerve-sparing radical prostatectomy: sailing in uncharted waters.
The Canadian journal of urology 2008;15(5):4230-2.
2008: Sun Jielin; Zheng Siqun Lilly; Wiklund Fredrik; Isaacs Sarah D; Purcell Lina D; Gao Zhengrong; Hsu Fang-Chi; Kim Seong-Tae; Liu Wennuan; Zhu Yi; Stattin Pär; Adami Hans-Olov; Wiley Kathleen E; Dimitrov Latchezar; Sun Jishan; Li Tao; Turner Aubrey R; Adams Tamara S; Adolfsson Jan; Johansson Jan-Erik; Lowey James; Trock Bruce J; Partin Alan W; Walsh Patrick C; Trent Jeffrey M; Duggan David; Carpten John; Chang Bao-Li; Grönberg Henrik; Isaacs William B; Xu Jianfeng
Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12.
Nature genetics 2008;40(10):1153-5.
2008: Loeb Stacy; Kettermann Anna; Carter H Ballentine; Ferrucci Luigi; Metter E Jeffrey; Walsh Patrick C
Does prostate growth confound prostate specific antigen velocity? Data from the Baltimore longitudinal study of aging.
The Journal of urology 2008;180(4):1314-7; discussion 1317.
2008: Xu Jianfeng; Isaacs Sarah D; Sun Jielin; Li Ge; Wiley Kathleen E; Zhu Yi; Hsu Fang-Chi; Wiklund Fredrik; Turner Aubrey R; Adams Tamara S; Liu Wennuan; Trock Bruce J; Partin Alan W; Chang Baoli; Walsh Patrick C; Grönberg Henrik; Isaacs William; Zheng Siqun
Association of prostate cancer risk variants with clinicopathologic characteristics of the disease.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(18):5819-24.
2008: Sun Jielin; Chang Bao-Li; Isaacs Sarah D; Wiley Kathleen E; Wiklund Fredrik; Stattin Pär; Duggan David; Carpten John D; Trock Bruce J; Partin Alan W; Walsh Patrick C; Grönberg Henrik; Xu Jianfeng; Isaacs William B; Zheng S Lilly
Cumulative effect of five genetic variants on prostate cancer risk in multiple study populations.
The Prostate 2008;68(12):1257-62.
2008: Nielsen Matthew E; Makarov Danil V; Humphreys Elizabeth; Mangold Leslie; Partin Alan W; Walsh Patrick C
Is it possible to compare PSA recurrence-free survival after surgery and radiotherapy using revised ASTRO criterion--"nadir + 2"?
Urology 2008;72(2):389-93; discussion 394-5.
2008: Hernandez David J; Nielsen Matthew E; Han Misop; Trock Bruce J; Partin Alan W; Walsh Patrick C; Epstein Jonathan I
Natural history of pathologically organ-confined (pT2), Gleason score 6 or less, prostate cancer after radical prostatectomy.
Urology 2008;72(1):172-6.
2008: Walsh Patrick C
How this doctor could save your mojo. Interview by Lawrence A Armour.
Fortune 2008;157(13):107, 108, 110.
2008: Trock Bruce J; Han Misop; Freedland Stephen J; Humphreys Elizabeth B; DeWeese Theodore L; Partin Alan W; Walsh Patrick C
Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy.
JAMA : the journal of the American Medical Association 2008;299(23):2760-9.
2008: Loeb Stacy; Hernandez David J; Mangold Leslie A; Humphreys Elizabeth B; Agro Marilyn; Walsh Patrick C; Partin Alan W; Han Misop
Progression after radical prostatectomy for men in their thirties compared to older men.
BJU international 2008;101(12):1503-6.
2008: Sun Jielin; Purcell Lina; Gao Zhengrong; Isaacs Sarah D; Wiley Kathleen E; Hsu Fang-Chi; Liu Wennuan; Duggan David; Carpten John D; Grönberg Henrik; Xu Jianfeng; Chang Bao-Li; Partin Alan W; Walsh Patrick C; Isaacs William B; Zheng S Lilly
Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African Americans.
The Prostate 2008;68(7):691-7.
2008: Sun Jielin; Lange Ethan M; Isaacs Sarah D; Liu Wennuan; Wiley Kathleen E; Lange Leslie; Gronberg Henrik; Duggan David; Carpten John D; Walsh Patrick C; Xu Jianfeng; Chang Bao-Li; Isaacs William B; Zheng S Lilly
Chromosome 8q24 risk variants in hereditary and non-hereditary prostate cancer patients.
The Prostate 2008;68(5):489-97.
2008: Müntener Michael; Epstein Jonathan I; Hernandez David J; Gonzalgo Mark L; Mangold Leslie; Humphreys Elizabeth; Walsh Patrick C; Partin Alan W; Nielsen Matthew E
Prognostic significance of Gleason score discrepancies between needle biopsy and radical prostatectomy.
European urology 2008;53(4):767-75; discussion 775-6.
2008: Gudmundsson Julius; Sulem Patrick; Rafnar Thorunn; Bergthorsson Jon T; Manolescu Andrei; Gudbjartsson Daniel; Agnarsson Bjarni A; Sigurdsson Asgeir; Benediktsdottir Kristrun R; Blondal Thorarinn; Jakobsdottir Margret; Stacey Simon N; Kostic Jelena; Kristinsson Kari T; Birgisdottir Birgitta; Ghosh Shyamali; Magnusdottir Droplaug N; Thorlacius Steinunn; Thorleifsson Gudmar; Zheng S Lilly; Sun Jielin; Chang Bao-Li; Elmore J Bradford; Breyer Joan P; McReynolds Kate M; Bradley Kevin M; Yaspan Brian L; Wiklund Fredrik; Stattin Par; Lindström Sara; Adami Hans-Olov; McDonnell Shannon K; Schaid Daniel J; Cunningham Julie M; Wang Liang; Cerhan James R; St Sauver Jennifer L; Isaacs Sara D; Wiley Kathleen E; Partin Alan W; Walsh Patrick C; Polo Sonia; Ruiz-Echarri Manuel; Navarrete Sebastian; Fuertes Fernando; Saez Berta; Godino Javier; Weijerman Philip C; Swinkels Dorine W; Aben Katja K; Witjes J Alfred; Suarez Brian K; Helfand Brian T; Frigge Michael L; Kristjansson Kristleifur; Ober Carole; Jonsson Eirikur; Einarsson Gudmundur V; Xu Jianfeng; Gronberg Henrik; Smith Jeffrey R; Thibodeau Stephen N; Isaacs William B; Catalona William J; Mayordomo Jose I; Kiemeney Lambertus A; Barkardottir Rosa B; Gulcher Jeffrey R; Thorsteinsdottir Unnur; Kong Augustine; Stefansson Kari
Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer.
Nature genetics 2008;40(3):281-3.
2008: Makarov Danil V; Humphreys Elizabeth B; Mangold Leslie A; Carducci Michael A; Partin Alan W; Eisenberger Mario A; Walsh Patrick C; Trock Bruce J
The natural history of men treated with deferred androgen deprivation therapy in whom metastatic prostate cancer developed following radical prostatectomy.
The Journal of urology 2008;179(1):156-61; discussion 161-2.
2007: Walsh Patrick C; DeWeese Theodore L; Eisenberger Mario A
Clinical practice. Localized prostate cancer.
The New England journal of medicine 2007;357(26):2696-705.
2007: Duggan David; Zheng Siqun L; Knowlton Michele; Benitez Debbie; Dimitrov Latchezar; Wiklund Fredrik; Robbins Christiane; Isaacs Sarah D; Cheng Yu; Li Ge; Sun Jielin; Chang Bao-Li; Marovich Leslie; Wiley Kathleen E; Bälter Katarina; Stattin Pär; Adami Hans-Olov; Gielzak Marta; Yan Guifang; Sauvageot Jurga; Liu Wennuan; Kim Jin Woo; Bleecker Eugene R; Meyers Deborah A; Trock Bruce J; Partin Alan W; Walsh Patrick C; Isaacs William B; Grönberg Henrik; Xu Jianfeng; Carpten John D
Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP.
Journal of the National Cancer Institute 2007;99(24):1836-44.
2007: Carter H Ballentine; Kettermann Anna; Warlick Christopher; Metter E Jeffrey; Landis Patricia; Walsh Patrick C; Epstein Jonathan I
Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience.
The Journal of urology 2007;178(6):2359-64; discussion 2364-5.
2007: Zheng S Lilly; Sun Jielin; Cheng Yu; Li Ge; Hsu Fang-Chi; Zhu Yi; Chang Bao-Li; Liu Wennuan; Kim Jin Woo; Turner Aubrey R; Gielzak Marta; Yan Guifang; Isaacs Sarah D; Wiley Kathleen E; Sauvageot Jurga; Chen Huann-Sheng; Gurganus Robin; Mangold Leslie A; Trock Bruce J; Gronberg Henrik; Duggan David; Carpten John D; Partin Alan W; Walsh Patrick C; Xu Jianfeng; Isaacs William B
Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.
Journal of the National Cancer Institute 2007;99(20):1525-33.
2007: Chuang Ai-Ying; Nielsen Matthew E; Hernandez David J; Walsh Patrick C; Epstein Jonathan I
The significance of positive surgical margin in areas of capsular incision in otherwise organ confined disease at radical prostatectomy.
The Journal of urology 2007;178(4 Pt 1):1306-10.
2007: Magheli Ahmed; Rais-Bahrami Soroush; Peck Hugh J; Walsh Patrick C; Epstein Jonathan I; Trock Bruce J; Gonzalgo Mark L
Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy.
The Journal of urology 2007;178(4 Pt 1):1311-5.
2007: Mohler James; Babaian Richard J; Bahnson Robert R; Boston Barry; D'Amico Anthony; Eastham James A; Hauke Ralph J; Huben Robert P; Kantoff Philip; Kawachi Mark; Kuettel Michael; Lange Paul H; Logothetis Chris; MacVicar Gary; Pollack Alan; Pow-Sang Julio M; Roach Mack; Sandler Howard; Shrieve Dennis; Srinivas Sandhya; Twardowski Przemyslaw; Urban Donald A; Walsh Patrick C;
Prostate cancer. Clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2007;5(7):650-83.
2007: Makarov Danil V; Trock Bruce J; Humphreys Elizabeth B; Mangold Leslie A; Walsh Patrick C; Epstein Jonathan I; Partin Alan W
Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005.
Urology 2007;69(6):1095-101.
2007: Camp Nicola J; Cannon-Albright Lisa A; Farnham James M; Baffoe-Bonnie Agnes B; George Asha; Powell Isaac; Bailey-Wilson Joan E; Carpten John D; Giles Graham G; Hopper John L; Severi Gianluca; English Dallas R; Foulkes William D; Maehle Lovise; Moller Pal; Eeles Ros; Easton Douglas; Badzioch Michael D; Whittemore Alice S; Oakley-Girvan Ingrid; Hsieh Chih-Lin; Dimitrov Latchezar; Xu Jianfeng; Stanford Janet L; Johanneson Bo; Deutsch Kerry; McIntosh Laura; Ostrander Elaine A; Wiley Kathleen E; Isaacs Sarah D; Walsh Patrick C; Thibodeau Stephen N; McDonnell Shannon K; Hebbring Scott; Schaid Daniel J; Lange Ethan M; Cooney Kathleen A; Tammela Teuvo L J; Schleutker Johanna; Paiss Thomas; Maier Christiane; Grönberg Henrik; Wiklund Fredrik; Emanuelsson Monica; Isaacs William B;
Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics.
Human molecular genetics 2007;16(11):1271-8.
2007: Freedland Stephen J; Humphreys Elizabeth B; Mangold Leslie A; Eisenberger Mario; Dorey Frederick J; Walsh Patrick C; Partin Alan W
Death in patients with recurrent prostate cancer after radical prostatectomy: prostate-specific antigen doubling time subgroups and their associated contributions to all-cause mortality.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(13):1765-71.
2007: Walsh Patrick Craig
The discovery of the cavernous nerves and development of nerve sparing radical retropubic prostatectomy.
The Journal of urology 2007;177(5):1632-5.
2007: Gudmundsson Julius; Sulem Patrick; Manolescu Andrei; Amundadottir Laufey T; Gudbjartsson Daniel; Helgason Agnar; Rafnar Thorunn; Bergthorsson Jon T; Agnarsson Bjarni A; Baker Adam; Sigurdsson Asgeir; Benediktsdottir Kristrun R; Jakobsdottir Margret; Xu Jianfeng; Blondal Thorarinn; Kostic Jelena; Sun Jielin; Ghosh Shyamali; Stacey Simon N; Mouy Magali; Saemundsdottir Jona; Backman Valgerdur M; Kristjansson Kristleifur; Tres Alejandro; Partin Alan W; Albers-Akkers Marjo T; Godino-Ivan Marcos Javier; Walsh Patrick C; Swinkels Dorine W; Navarrete Sebastian; Isaacs Sarah D; Aben Katja K; Graif Theresa; Cashy John; Ruiz-Echarri Manuel; Wiley Kathleen E; Suarez Brian K; Witjes J Alfred; Frigge Mike; Ober Carole; Jonsson Eirikur; Einarsson Gudmundur V; Mayordomo Jose I; Kiemeney Lambertus A; Isaacs William B; Catalona William J; Barkardottir Rosa B; Gulcher Jeffrey R; Thorsteinsdottir Unnur; Kong Augustine; Stefansson Kari
Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24.
Nature genetics 2007;39(5):631-7.
2007: Freedland Stephen J; Partin Alan W; Humphreys Elizabeth B; Mangold Leslie A; Walsh Patrick C
Radical prostatectomy for clinical stage T3a disease.
Cancer 2007;109(7):1273-8.
2006: Walsh Patrick C
Re: The Prostate Cancer Prevention Trial: design, biases and interpretation of study results. P. J. Goodman, I. M. Thompson, Jr., C. M. Tangen, J. J. Crowley, L. G. Ford and C. A. Coltman, Jr., J Urol, 175: 2234-2242, 2006.
The Journal of urology 2006;176(6 Pt 1):2744; author reply 2744.
2006: Schaid Daniel J; McDonnell Shannon K; Zarfas Katherine E; Cunningham Julie M; Hebbring Scott; Thibodeau Stephen N; Eeles Rosalind A; Easton Douglas F; Foulkes William D; Simard Jacques; Giles Graham G; Hopper John L; Mahle Lovise; Moller Pal; Badzioch Michael; Bishop D Timothy; Evans Chris; Edwards Steve; Meitz Julia; Bullock Sarah; Hope Questa; Guy Michelle; Hsieh Chih-lin; Halpern Jerry; Balise Raymond R; Oakley-Girvan Ingrid; Whittemore Alice S; Xu Jianfeng; Dimitrov Latchezar; Chang Bao-Li; Adams Tamara S; Turner Aubrey R; Meyers Deborah A; Friedrichsen Danielle M; Deutsch Kerry; Kolb Suzanne; Janer Marta; Hood Leroy; Ostrander Elaine A; Stanford Janet L; Ewing Charles M; Gielzak Marta; Isaacs Sarah D; Walsh Patrick C; Wiley Kathleen E; Isaacs William B; Lange Ethan M; Ho Lindsey A; Beebe-Dimmer Jennifer L; Wood David P; Cooney Kathleen A; Seminara Daniela; Ikonen Tarja; Baffoe-Bonnie Agnes; Fredriksson Henna; Matikainen Mika P; Tammela Teuvo L J; Bailey-Wilson Joan; Schleutker Johanna; Maier Christiane; Herkommer Kathleen; Hoegel Josef J; Vogel Walther; Paiss Thomas; Wiklund Fredrik; Emanuelsson Monica; Stenman Elisabeth; Jonsson Björn-Anders; Grönberg Henrik; Camp Nicola J; Farnham James; Cannon-Albright Lisa A; Catalona William J; Suarez Brian K; Roehl Kimberly A;
Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics.
Human genetics 2006;120(4):471-85.
2006: Makarov Danil V; Humphreys Elizabeth B; Mangold Leslie A; Walsh Patrick C; Partin Alan W; Epstein Jonathan I; Freedland Stephen J
Pathological outcomes and biochemical progression in men with T1c prostate cancer undergoing radical prostatectomy with prostate specific antigen 2.6 to 4.0 vs 4.1 to 6.0 ng/ml.
The Journal of urology 2006;176(2):554-8.
2006: Nielsen Matthew E; Han Misop; Mangold Leslie; Humphreys Elizabeth; Walsh Patrick C; Partin Alan W; Freedland Stephen J
Black race does not independently predict adverse outcome following radical retropubic prostatectomy at a tertiary referral center.
The Journal of urology 2006;176(2):515-9.
2006: Walsh Patrick C
Re: Long-term effects of finasteride on prostate specific antigen levels: results from the Prostate Cancer Prevention Trial.
The Journal of urology 2006;176(1):409-10; author reply 410.
2006: Rohrmann Sabine; Fallin M Daniele; Page William F; Reed Terry; Partin Alan W; Walsh Patrick C; Platz Elizabeth A
Concordance rates and modifiable risk factors for lower urinary tract symptoms in twins.
Epidemiology (Cambridge, Mass.) 2006;17(4):419-27.
2006: Xu Junyan; Sauvageot Jurga; Ewing Charles M; Sun Jielin; Liu Wennuan; Isaacs Sarah D; Wiley Kathleen E; Diaz Lina; Zheng S Lilly; Walsh Patrick C; Isaacs William B
Germline ATBF1 mutations and prostate cancer risk.
The Prostate 2006;66(10):1082-5.
2006: Chang Bao-Li; Lange Ethan M; Dimitrov Latchezar; Valis Christopher J; Gillanders Elizabeth M; Lange Leslie A; Wiley Kathleen E; Isaacs Sarah D; Wiklund Fredrik; Baffoe-Bonnie Agnes; Langefeld Carl D; Zheng S Lilly; Matikainen Mika P; Ikonen Tarja; Fredriksson Henna; Tammela Teuvo; Walsh Patrick C; Bailey-Wilson Joan E; Schleutker Johanna; Gronberg Henrik; Cooney Kathleen A; Isaacs William B; Suh Edward; Trent Jeffrey M; Xu Jianfeng
Two-locus genome-wide linkage scan for prostate cancer susceptibility genes with an interaction effect.
Human genetics 2006;118(6):716-24.
2006: Rohrmann Sabine; Fallin M Daniele; Page William F; Reed Terry; Partin Alan W; Walsh Patrick C; Platz Elizabeth A
Re: "Obesity and hormone-dependent tumors: cohort and co-twin control studies based on the Swedish twin registry".
International journal of cancer. Journal international du cancer 2006;118(3):785.
2006: Gonzalgo Mark L; Bastian Patrick J; Mangold Leslie A; Trock Bruce J; Epstein Jonathan I; Walsh Patrick C; Partin Alan W
Relationship between primary Gleason pattern on needle biopsy and clinicopathologic outcomes among men with Gleason score 7 adenocarcinoma of the prostate.
Urology 2006;67(1):115-9.
2006: Zheng S Lilly; Ju Jeong-ho; Chang Bao-li; Ortner Elizabeth; Sun Jielin; Isaacs Sarah D; Sun Jishang; Wiley Kathy E; Liu Wennuan; Zemedkun Micheas; Walsh Patrick C; Ferretti James; Gruschus James; Isaacs William B; Gelmann Edward P; Xu Jianfeng
Germ-line mutation of NKX3.1 cosegregates with hereditary prostate cancer and alters the homeodomain structure and function.
Cancer research 2006;66(1):69-77.
2005: Wu Christopher L; Rowlingson Andrew J; Partin Alan W; Kalish Murray A; Courpas Genevieve E; Walsh Patrick C; Fleisher Lee A
Correlation of postoperative pain to quality of recovery in the immediate postoperative period.
Regional anesthesia and pain medicine 2005;30(6):516-22.
2005: Nielsen Matthew E; Walsh Patrick C
Systematic detection and repair of subclinical inguinal hernias at radical retropubic prostatectomy.
Urology 2005;66(5):1034-7.
2005: Walsh Patrick C
The association of body mass index and prostate-specific antigen in a population-based study.
The Journal of urology 2005;174(5):1825.
2005: Walsh Patrick C
Observed effect of age and body mass index on total and complexed PSA: analysis from a National Screening Program.
The Journal of urology 2005;174(5):1825-6.
2005: Walsh Patrick C
Serum levels of phytanic acid are associated with prostate cancer risk.
The Journal of urology 2005;174(5):1824.
2005: Walsh Patrick C
Screening by prostate-specific antigen and digital rectal examination in relation to prostate cancer mortality. A case-control study.
The Journal of urology 2005;174(5):1824-5.
2005: Walsh Patrick C
Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.
The Journal of urology 2005;174(5):1823-4.
2005: Walsh Patrick C
Re: Ultrasensitive serum prostate specific antigen nadir accurately predicts the risk of early relapse after radical prostatectomy.
The Journal of urology 2005;174(4 Pt 1):1500-1; author reply 1501.
2005: Walsh Patrick C
Geographic patterns of prostate cancer mortality and variations in access to medical care in the United States.
The Journal of urology 2005;174(4 Pt 1):1294-5.
2005: Walsh Patrick C
Estimated impact of the prostate cancer prevention trial on population mortality.
The Journal of urology 2005;174(4 Pt 1):1293.
2005: Walsh Patrick C
Implications of the prostate cancer prevention trial: a decision analysis model of survival outcomes.
The Journal of urology 2005;174(4 Pt 1):1293-4.
2005: Walsh Patrick C
20-year outcomes following conservative management of clinically localized prostate cancer.
The Journal of urology 2005;174(4 Pt 1):1292-3.
2005: Walsh Patrick C
Radical prostatectomy versus watchful waiting in early prostate cancer.
The Journal of urology 2005;174(4 Pt 1):1291-2.
2005: Freedland Stephen J; Mangold Leslie A; Walsh Patrick C; Partin Alan W
The prostatic specific antigen era is alive and well: prostatic specific antigen and biochemical progression following radical prostatectomy.
The Journal of urology 2005;174(4 Pt 1):1276-81; discussion 1281; author reply 1281.
2005: Walsh Patrick C
Immediate versus deferred hormonal treatment for patients with prostate cancer who are not suitable for curative local treatment: results of the randomized trial SAKK 08/88.
The Journal of urology 2005;174(3):929.
2005: Walsh Patrick C
Risk of fracture after androgen deprivation for prostate cancer.
The Journal of urology 2005;174(3):929-30.
2005: Walsh Patrick C
Failure definition-dependent differences in outcome following radiation for localized prostate cancer: can one size fit all?
The Journal of urology 2005;174(3):928-9.
2005: Chang Bao-Li; Isaacs Sarah D; Wiley Kathy E; Gillanders Elizabeth M; Zheng S Lilly; Meyers Deborah A; Walsh Patrick C; Trent Jeffrey M; Xu Jianfeng; Isaacs William B
Genome-wide screen for prostate cancer susceptibility genes in men with clinically significant disease.
The Prostate 2005;64(4):356-61.
2005: Wu Christopher L; Partin Alan W; Rowlingson Andrew J; Kalish Murray A; Walsh Patrick C; Fleisher Lee A
Efficacy of continuous local anesthetic infusion for postoperative pain after radical retropubic prostatectomy.
Urology 2005;66(2):366-70.
2005: Walsh Patrick C
Laparoscopic radical prostatectomy: is intact organ removal attainable? Study of margin status.
The Journal of urology 2005;174(2):568.
2005: Walsh Patrick C
Variation in course of cavernous nerve with special reference to details of topographic relationships near prostatic apex: histologic study using male cadavers.
The Journal of urology 2005;174(2):567.
2005: Walsh Patrick C
Extraperitoneal standard laparoscopic radical prostatectomy.
The Journal of urology 2005;174(2):567-8.
2005: Walsh Patrick C
Anatomical studies of the neurovascular bundle and cavernosal nerves.
The Journal of urology 2005;174(2):566.
2005: Xu Jianfeng; Dimitrov Latchezar; Chang Bao-Li; Adams Tamara S; Turner Aubrey R; Meyers Deborah A; Eeles Rosalind A; Easton Douglas F; Foulkes William D; Simard Jacques; Giles Graham G; Hopper John L; Mahle Lovise; Moller Pal; Bishop Tim; Evans Chris; Edwards Steve; Meitz Julia; Bullock Sarah; Hope Questa; Hsieh Chih-Lin; Halpern Jerry; Balise Raymond N; Oakley-Girvan Ingrid; Whittemore Alice S; Ewing Charles M; Gielzak Marta; Isaacs Sarah D; Walsh Patrick C; Wiley Kathleen E; Isaacs William B; Thibodeau Stephen N; McDonnell Shannon K; Cunningham Julie M; Zarfas Katherine E; Hebbring Scott; Schaid Daniel J; Friedrichsen Danielle M; Deutsch Kerry; Kolb Suzanne; Badzioch Michael; Jarvik Gail P; Janer Marta; Hood Leroy; Ostrander Elaine A; Stanford Janet L; Lange Ethan M; Beebe-Dimmer Jennifer L; Mohai Caroline E; Cooney Kathleen A; Ikonen Tarja; Baffoe-Bonnie Agnes; Fredriksson Henna; Matikainen Mika P; Tammela Teuvo Lj; Bailey-Wilson Joan; Schleutker Johanna; Maier Christiane; Herkommer Kathleen; Hoegel Josef J; Vogel Walther; Paiss Thomas; Wiklund Fredrik; Emanuelsson Monica; Stenman Elisabeth; Jonsson Bjorn-Anders; Gronberg Henrik; Camp Nicola J; Farnham James; Cannon-Albright Lisa A; Seminara Daniela;
A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics.
American journal of human genetics 2005;77(2):219-29.
2005: Freedland Stephen J; Humphreys Elizabeth B; Mangold Leslie A; Eisenberger Mario; Dorey Frederick J; Walsh Patrick C; Partin Alan W
Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy.
JAMA : the journal of the American Medical Association 2005;294(4):433-9.
2005: Walsh Patrick C
High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate. Cancer patients treated with radical prostatectomy.
The Journal of urology 2005;173(6):1967-8.
2005: Walsh Patrick C
American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer.
The Journal of urology 2005;173(6):1966.
2005: Walsh Patrick C
Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer.
The Journal of urology 2005;173(6):1966-7.
2005: Freedland Stephen J; Isaacs William B; Mangold Leslie A; Yiu Sindy K; Grubb Kelly A; Partin Alan W; Epstein Jonathan I; Walsh Patrick C; Platz Elizabeth A
Stronger association between obesity and biochemical progression after radical prostatectomy among men treated in the last 10 years.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(8):2883-8.
2005: Walsh Patrick C
Delayed intraoperative hydration limits blood loss during radical retropubic prostatectomy.
The Journal of urology 2005;173(4):1171.
2005: Walsh Patrick C
Alcohol consumption and risk of prostate cancer in middle-aged men.
The Journal of urology 2005;173(4):1170.
2005: Walsh Patrick C
Prostate cancer screening and mortality: a case-control study (United States).
The Journal of urology 2005;173(4):1170-1.
2005: Walsh Patrick C
Hedgehog signalling in prostate regeneration, neoplasia and metastasis.
The Journal of urology 2005;173(4):1169.
2005: Chang Bao-Li; Gillanders Elizabeth M; Isaacs Sarah D; Wiley Kathy E; Adams Tamara; Turner Aubrey R; Zheng S Lilly; Meyers Deborah A; Carpten John D; Walsh Patrick C; Trent Jeffrey M; Xu Jianfeng; Isaacs William B
Evidence for a general cancer susceptibility locus at 3p24 in families with hereditary prostate cancer.
Cancer letters 2005;219(2):177-82.
2005: Walsh Patrick C
Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging.
The Journal of urology 2005;173(3):832.
2005: Walsh Patrick C
The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy.
The Journal of urology 2005;173(3):831-2.
2005: Walsh Patrick C
Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy.
The Journal of urology 2005;173(3):830.
2005: Walsh Patrick C
Prostate cancer localization with endorectal MR imaging and MR spectroscopic imaging: effect of clinical data on reader accuracy.
The Journal of urology 2005;173(3):830-1.
2005: Narla Goutham; Difeo Analisa; Reeves Helen L; Schaid Daniel J; Hirshfeld Jennifer; Hod Eldad; Katz Amanda; Isaacs William B; Hebbring Scott; Komiya Akira; McDonnell Shannon K; Wiley Kathleen E; Jacobsen Steven J; Isaacs Sarah D; Walsh Patrick C; Zheng S Lilly; Chang Bao-Li; Friedrichsen Danielle M; Stanford Janet L; Ostrander Elaine A; Chinnaiyan Arul M; Rubin Mark A; Xu Jianfeng; Thibodeau Stephen N; Friedman Scott L; Martignetti John A
A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk.
Cancer research 2005;65(4):1213-22.
2005: Tsuzuki Toyonori; Hernandez David J; Aydin Hakan; Trock Bruce; Walsh Patrick C; Epstein Jonathan I
Prediction of extraprostatic extension in the neurovascular bundle based on prostate needle biopsy pathology, serum prostate specific antigen and digital rectal examination.
The Journal of urology 2005;173(2):450-3.
2005: Hernandez David J; Epstein Jonathan I; Trock Bruce J; Tsuzuki Toyonori; Carter H Ballentine; Walsh Patrick C
Radical retropubic prostatectomy. How often do experienced surgeons have positive surgical margins when there is extraprostatic extension in the region of the neurovascular bundle?
The Journal of urology 2005;173(2):446-9.
2005: Walsh P C
Re: Anatomical radical retropubic prostatectomy: detailed description of the surgical technique.
The Journal of urology 2005;173(1):324.
2005: Walsh Patrick C
Proscar and Propecia--a therapeutic perspective.
The Journal of urology 2005;173(1):88.
2005: Walsh Patrick C
Residential sunlight exposure is associated with a decreased risk of prostate cancer.
The Journal of urology 2005;173(1):87.
2005: Walsh Patrick C
Cancer in US Air Force Veterans of the Vietnam War.
The Journal of urology 2005;173(1):87.
2005: Walsh Patrick C
Vitamin E supplements and risk of prostate cancer in U.S. men.
The Journal of urology 2005;173(1):87-8.
2004: Walsh Patrick C
BJU International June issue DVD.
BJU international 2004;94(7):1143.
2004: Palapattu Ganesh S; Allaf Mohamad E; Trock Bruce J; Epstein Jonathan I; Walsh Patrick C
Prostate specific antigen progression in men with lymph node metastases following radical prostatectomy: results of long-term followup.
The Journal of urology 2004;172(5 Pt 1):1860-4.
2004: Allaf Mohamad E; Palapattu Ganesh S; Trock Bruce J; Carter H Ballentine; Walsh Patrick C
Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer.
The Journal of urology 2004;172(5 Pt 1):1840-4.
2004: Khan Masood A; Mangold Leslie A; Epstein Jonathan I; Boitnott John K; Walsh Patrick C; Partin Alan W
Impact of surgical delay on long-term cancer control for clinically localized prostate cancer.
The Journal of urology 2004;172(5 Pt 1):1835-9.
2004: Parsons J Kellogg; Marschke Penny; Maples Patricia; Walsh Patrick C
Effect of methylprednisolone on return of sexual function after nerve-sparing radical retropubic prostatectomy.
Urology 2004;64(5):987-90.
2004: Faith Dennis A; Isaacs William B; Morgan James D; Fedor Helen L; Hicks Jessica L; Mangold Leslie A; Walsh Patrick C; Partin Alan W; Platz Elizabeth A; Luo Jun; De Marzo Angelo M
Trefoil factor 3 overexpression in prostatic carcinoma: prognostic importance using tissue microarrays.
The Prostate 2004;61(3):215-27.
2004: Ong Albert M; Su Li-Ming; Varkarakis Ioannis; Inagaki Takeshi; Link Richard E; Bhayani Sam B; Patriciu Alex; Crain Barbara; Walsh Patrick C
Nerve sparing radical prostatectomy: effects of hemostatic energy sources on the recovery of cavernous nerve function in a canine model.
The Journal of urology 2004;172(4 Pt 1):1318-22.
2004: Aydin Hakan; Tsuzuki Toyonori; Hernandez David; Walsh Patrick C; Partin Alan W; Epstein Jonathan I
Positive proximal (bladder neck) margin at radical prostatectomy confers greater risk of biochemical progression.
Urology 2004;64(3):551-5.
2004: Hawkins Gregory A; Chang Bao-Li; Zheng S Lilly; Isaacs Sarah D; Wiley Kathleen E; Bleecker Eugene R; Walsh Patrick C; Meyers Deborah A; Xu Jianfeng; Isaacs William B
Mutational analysis of PINX1 in hereditary prostate cancer.
The Prostate 2004;60(4):298-302.
2004: Gillanders Elizabeth M; Xu Jianfeng; Chang Bao-li; Lange Ethan M; Wiklund Fredrik; Bailey-Wilson Joan E; Baffoe-Bonnie Agnes; Jones MaryPat; Gildea Derek; Riedesel Erica; Albertus Julie; Isaacs Sarah D; Wiley Kathleen E; Mohai Caroline E; Matikainen Mika P; Tammela Teuvo L J; Zheng S Lilly; Brown W Mark; Rökman Annika; Carpten John D; Meyers Deborah A; Walsh Patrick C; Schleutker Johanna; Gronberg Henrik; Cooney Kathleen A; Isaacs William B; Trent Jeffrey M
Combined genome-wide scan for prostate cancer susceptibility genes.
Journal of the National Cancer Institute 2004;96(16):1240-7.
2004: Xu Jianfeng; Langefeld Carl D; Zheng S Lilly; Gillanders Elizabeth M; Chang Bao-Li; Isaacs Sarah D; Williams Adrienne H; Wiley Kathy E; Dimitrov Latchezar; Meyers Deborah A; Walsh Patrick C; Trent Jeffrey M; Isaacs William B
Interaction effect of PTEN and CDKN1B chromosomal regions on prostate cancer linkage.
Human genetics 2004;115(3):255-62.
2004: Rogers Craig G; Trock Bruce P; Walsh Patrick C
Preservation of accessory pudendal arteries during radical retropubic prostatectomy: surgical technique and results.
Urology 2004;64(1):148-51.
2004: Schaeffer Edward M; Epstein Jonathan I; Walsh Patrick C
Amyloidosis of the seminal vesicle and hematospermia.
The Journal of urology 2004;171(6 Pt 1):2382.
2004: Veltri Robert W; Khan Masood A; Miller M Craig; Epstein Jonathan I; Mangold Leslie A; Walsh Patrick C; Partin Alan W
Ability to predict metastasis based on pathology findings and alterations in nuclear structure of normal-appearing and cancer peripheral zone epithelium in the prostate.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(10):3465-73.
2004: Schaeffer Edward M; Walsh Patrick C
Risks of testosterone replacement.
The New England journal of medicine 2004;350(19):2004-6; author reply 2004-6.
2004: Freedland Stephen J; Partin Alan W; Epstein Jonathan I; Walsh Patrick C
Biochemical failure after radical prostatectomy in men with pathologic organ-confined disease: pT2a versus pT2b.
Cancer 2004;100(8):1646-9.
2004: Carter H Ballentine; Metter E Jeffrey; Wright James; Landis Patricia; Platz Elizabeth; Walsh Patrick C
Prostate-specific antigen and all-cause mortality: results from the Baltimore Longitudinal Study On Aging.
Journal of the National Cancer Institute 2004;96(7):557-8.
2004: Walsh Patrick C
Re: variation in continence and potency by definition.
The Journal of urology 2004;171(4):1635; author reply.
2004: Chang Bao-li; Zheng Siqun L; Isaacs Sarah D; Wiley Kathy E; Turner Aubrey; Li Ge; Walsh Patrick C; Meyers Deborah A; Isaacs William B; Xu Jianfeng
A polymorphism in the CDKN1B gene is associated with increased risk of hereditary prostate cancer.
Cancer research 2004;64(6):1997-9.
2004: Yegnasubramanian Srinivasan; Kowalski Jeanne; Gonzalgo Mark L; Zahurak Marianna; Piantadosi Steven; Walsh Patrick C; Bova G Steven; De Marzo Angelo M; Isaacs William B; Nelson William G
Hypermethylation of CpG islands in primary and metastatic human prostate cancer.
Cancer research 2004;64(6):1975-86.
2004: Friedrichsen Danielle M; Stanford Janet L; Isaacs Sarah D; Janer Marta; Chang Bao-Li; Deutsch Kerry; Gillanders Elizabeth; Kolb Suzanne; Wiley Katherine E; Badzioch Michael D; Zheng S Lilly; Walsh Patrick C; Jarvik Gail P; Hood Leroy; Trent Jeffrey M; Isaacs William B; Ostrander Elaine A; Xu Jianfeng
Identification of a prostate cancer susceptibility locus on chromosome 7q11-21 in Jewish families.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(7):1939-44.
2004: Brown W M; Lange E M; Chen H; Zheng S L; Chang B; Wiley K E; Isaacs S D; Walsh P C; Isaacs W B; Xu J; Cooney K A
Hereditary prostate cancer in African American families: linkage analysis using markers that map to five candidate susceptibility loci.
British journal of cancer 2004;90(2):510-4.
2004: Han Misop; Partin Alan W; Chan David Y; Walsh Patrick C
An evaluation of the decreasing incidence of positive surgical margins in a large retropubic prostatectomy series.
The Journal of urology 2004;171(1):23-6.
2003: Cannon Glenn M; Walsh Patrick C; Partin Alan W; Pound Charles R
Prostate-specific antigen doubling time in the identification of patients at risk for progression after treatment and biochemical recurrence for prostate cancer.
Urology 2003;62 Suppl 1():2-8.
2003: Khan Masood A; Walsh Patrick C; Miller M Craig; Bales Wesley D; Epstein Jonathan I; Mangold Leslie A; Partin Alan W; Veltri Robert W
Quantitative alterations in nuclear structure predict prostate carcinoma distant metastasis and death in men with biochemical recurrence after radical prostatectomy.
Cancer 2003;98(12):2583-91.
2003: Xu Jianfeng; Gillanders Elizabeth M; Isaacs Sarah D; Chang Bao-Li; Wiley Kathy E; Zheng S Lilly; Jones MaryPat; Gildea Derek; Riedesel Erica; Albertus Julie; Freas-Lutz Diana; Markey Carol; Meyers Deborah A; Walsh Patrick C; Trent Jeffrey M; Isaacs William B
Genome-wide scan for prostate cancer susceptibility genes in the Johns Hopkins hereditary prostate cancer families.
The Prostate 2003;57(4):320-5.
2003: Khan Masood A; Partin Alan W; Mangold Leslie A; Epstein Jonathan I; Walsh Patrick C
Probability of biochemical recurrence by analysis of pathologic stage, Gleason score, and margin status for localized prostate cancer.
Urology 2003;62(5):866-71.
2003: Harden Susan V; Sanderson Harriette; Goodman Steven N; Partin Alan A W; Walsh Patrick C; Epstein Jonathan I; Sidransky David
Quantitative GSTP1 methylation and the detection of prostate adenocarcinoma in sextant biopsies.
Journal of the National Cancer Institute 2003;95(21):1634-7.
2003: Chang B L; Zheng S L; Isaacs S D; Turner A; Hawkins G A; Wiley K E; Bleecker E R; Walsh P C; Meyers D A; Isaacs W B; Xu J
Polymorphisms in the CYP1B1 gene are associated with increased risk of prostate cancer.
British journal of cancer 2003;89(8):1524-9.
2003: Luo Jun; Dunn Thomas A; Ewing Charles M; Walsh Patrick C; Isaacs William B
Decreased gene expression of steroid 5 alpha-reductase 2 in human prostate cancer: implications for finasteride therapy of prostate carcinoma.
The Prostate 2003;57(2):134-9.
2003: Chang Bao-li; Zheng Siqun L; Isaacs Sarah D; Turner Aubrey; Hawkins Gregory A; Wiley Kathy E; Bleecker Eugene R; Walsh Patrick C; Meyers Deborah A; Isaacs William B; Xu Jianfeng
Polymorphisms in the CYP1A1 gene are associated with prostate cancer risk.
International journal of cancer. Journal international du cancer 2003;106(3):375-8.
2003: Walsh Patrick C
Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7/SFUO-3.
The Journal of urology 2003;170(1):320.
2003: Walsh Patrick C
Impact of radical prostatectomy and TURP on the hypothalamic-pituitary-gonadal hormone axis.
The Journal of urology 2003;170(1):319-20.
2003: Walsh Patrick C
Major postoperative complications secondary to use of the Bookwalter self-retaining retractor.
The Journal of urology 2003;170(1):319.
2003: Walsh Patrick C
Prospective comparison of radical retropubic prostatectomy and robot-assisted anatomic prostatectomy: the Vattikuti Urology Institute experience.
The Journal of urology 2003;170(1):318-9.
2003: Walsh Patrick C
Laparoscopic radical prostatectomy: initial 70 cases at a U.S. university medical center.
The Journal of urology 2003;170(1):318.
2003: Walsh Patrick C
Substratification of stage T1c prostate cancer based on the probability of biochemical recurrence.
The Journal of urology 2003;170(1):317.
2003: Walsh Patrick C
Influence of prostate volume in the detection of prostate cancer.
The Journal of urology 2003;170(1):316-7.
2003: Walsh Patrick C
Prostate cancer diagnosed after initial biopsy with atypical small acinar proliferation suspicious for malignancy is similar to cancer found on initial biopsy.
The Journal of urology 2003;170(1):316.
2003: Walsh Patrick C
Predictors of cancer in repeat extended multisite prostate biopsy in men with previous negative extended multisite biopsy.
The Journal of urology 2003;170(1):315-6.
2003: Walsh Patrick C
Acceptability and complications of prostate biopsy in population-based PSA screening versus routine clinical practice: a prospective, controlled study.
The Journal of urology 2003;170(1):315.
2003: Walsh Patrick C
Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program.
The Journal of urology 2003;170(1):314.
2003: Walsh Patrick C
Mass screening for prostate cancer: a comparative study in Natori, Japan and Changchun, China.
The Journal of urology 2003;170(1):314.
2003: Walsh Patrick C
Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends.
The Journal of urology 2003;170(1):313-4.
2003: Walsh Patrick C
Screening for prostate cancer: recommendation and rationale.
The Journal of urology 2003;170(1):313.
2003: Walsh Patrick C
Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force.
The Journal of urology 2003;170(1):312-3.
2003: Walsh Patrick C
Calcium intake and prostate cancer risk in a long-term aging study: The Baltimore Logitudinal Study of Aging.
The Journal of urology 2003;170(1):312.
2003: Zheng Siqun L; Mychaleckyj Josyf C; Hawkins Gregory A; Isaacs Sarah D; Wiley Kathy E; Turner Aubrey; Chang Bao-li; von Kap-Herr Chris; Carpten John D; Pettenati Mark; Bleecker Eugene R; Walsh Patrick C; Trent Jeffrey M; Meyers Deborah A; Isaacs William B; Xu Jianfeng
Evaluation of DLC1 as a prostate cancer susceptibility gene: mutation screen and association study.
Mutation research 2003;528(1-2):45-53.
2003: Khan Masood A; Han Misop; Partin Alan W; Epstein Jonathan I; Walsh Patrick C
Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003.
Urology 2003;62(1):86-91; discussion 91-2.
2003: Chang Bao-Li; Zheng S Lilly; Isaacs Sarah D; Turner Aubrey R; Bleecker Eugene R; Walsh Patrick C; Meyers Deborah A; Isaacs William B; Xu Jianfeng
Evaluation of SRD5A2 sequence variants in susceptibility to hereditary and sporadic prostate cancer.
The Prostate 2003;56(1):37-44.
2003: Rohrmann Sabine; Roberts William W; Walsh Patrick C; Platz Elizabeth A
Family history of prostate cancer and obesity in relation to high-grade disease and extraprostatic extension in young men with prostate cancer.
The Prostate 2003;55(2):140-6.
2003: Gonzalgo Mark L; Walsh Patrick C
Balloon cuffing and management of the entrapped Foley catheter.
Urology 2003;61(4):825-7.
2003: Lowe Franklin C; McConnell John D; Hudson Perry B; Romas Nicholas A; Boake Rex; Lieber Michael; Elhilali Mostafa; Geller Jack; Imperto-McGinely Juliane; Andriole Gerald L; Bruskewitz Reginald C; Walsh Patrick C; Bartsch Georg; Nacey John N; Shah Sukrut; Pappas Frances; Ko Amy; Cook Thomas; Stoner Elizabeth; Waldstreicher Joanne;
Long-term 6-year experience with finasteride in patients with benign prostatic hyperplasia.
Urology 2003;61(4):791-6.
2003: Pearson Jay D; Lei Hsien-Hsien; Beaty Terri H; Wiley Kathleen E; Isaacs Sarah D; Isaacs William B; Stoner Elizabeth; Walsh Patrick C
Familial aggregation of bothersome benign prostatic hyperplasia symptoms.
Urology 2003;61(4):781-5.
2003: Walsh Patrick C
Altered cognitive function in men treated for prostate cancer with leutinizing hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled study.
The Journal of urology 2003;169(4):1598.
2003: Walsh Patrick C
The impact of androgen deprivation on quality of life after radical prostatectomy for prostate carcinoma.
The Journal of urology 2003;169(4):1597-8.
2003: Walsh Patrick C
Predictive factors of urinary retention following prostate brachytherapy.
The Journal of urology 2003;169(4):1597.
2003: Walsh Patrick C
Post-nerve-sparing prostatectomy, dose-escalated intensity-modulated radiotherapy: effect on erectile dysfunction.
The Journal of urology 2003;169(4):1596-7.
2003: Walsh Patrick C
(In)-efficacy of salvage radiotherapy for rising PSA or clinically isolated local recurrence after radical prostatectomy.
The Journal of urology 2003;169(4):1596, 1597.
2003: Walsh Patrick C
Postoperative radiotherapy in 423 patients with pT30NO prostate cancer.
The Journal of urology 2003;169(4):1595, 1597.
2003: Walsh Patrick C
Defining sexual outcomes after treatment for localized prostate carcinoma.
The Journal of urology 2003;169(4):1594-5.
2003: Walsh Patrick C
Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiation.
The Journal of urology 2003;169(4):1593, 1594.
2003: Walsh Patrick C
Dietary supplement use in the Prostate Cancer Prevention trial: implications for prevention trials.
The Journal of urology 2003;169(4):1593.
2003: Walsh Patrick C
Lack of effect of a low-fat, high-fruit, -vegetable, and -fiber diet on serum prostate-specific antigen of men without prostate cancer: results from a randomized trial.
The Journal of urology 2003;169(4):1592-3.
2003: Walsh Patrick C
Serum proteomic patterns for detection of prostate cancer.
The Journal of urology 2003;169(4):1592.
2003: Walsh Patrick C
RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases.
The Journal of urology 2003;169(4):1591.
2003: Walsh Patrick C
A novel founder mutation in the RNASEL gene, 471delAAAG, is associated with prostate cancer in Ashkenazi Jews.
The Journal of urology 2003;169(4):1591.
2003: Walsh Patrick C
Germline mutations and sequence variants of macrophage scavenger receptor 1 gene are associated with prostate cancer risk.
The Journal of urology 2003;169(4):1589-90.
2003: Walsh Patrick C
Quality of life after radical prostatectomy or watchful waiting.
The Journal of urology 2003;169(4):1588-9.
2003: Walsh Patrick C
A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer.
The Journal of urology 2003;169(4):1588, 1589.
2003: Han Misop; Partin Alan W; Zahurak Marianna; Piantadosi Steven; Epstein Johnathan I; Walsh Patrick C
Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.
The Journal of urology 2003;169(2):517-23.
2003: Roberts William W; Platz Elizabeth A; Walsh Patrick C
Association of cigarette smoking with extraprostatic prostate cancer in young men.
The Journal of urology 2003;169(2):512-6; discussion 516.
2003: Xu Jianfeng; Zheng S Lilly; Komiya Akira; Mychaleckyj Josyf C; Isaacs Sarah D; Chang Baoli; Turner Aubrey R; Ewing Charles M; Wiley Kathleen E; Hawkins Gregory A; Bleecker Eugene R; Walsh Patrick C; Meyers Deborah A; Isaacs William B
Common sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk.
American journal of human genetics 2003;72(1):208-12.
2002: Gretzer Matthew B; Epstein Jonathan I; Pound Charles R; Walsh Patrick C; Partin Alan W
Substratification of stage T1C prostate cancer based on the probability of biochemical recurrence.
Urology 2002;60(6):1034-9.
2002: Zheng Siqun L; Chang Bao-li; Faith Dennis A; Johnson Jill R; Isaacs Sarah D; Hawkins Gregory A; Turner Aubrey; Wiley Kathy E; Bleecker Eugene R; Walsh Patrick C; Meyers Deborah A; Isaacs William B; Xu Jianfeng
Sequence variants of alpha-methylacyl-CoA racemase are associated with prostate cancer risk.
Cancer research 2002;62(22):6485-8.
2002: Hawkins Gregory A; Cramer Scott D; Zheng Siqun L; Isaacs Sarah D; Wiley Kathy E; Chang Bao-Li; Bleecker Eugene R; Walsh Patrick C; Meyers Deborah A; Isaacs William B; Xu Jianfeng
Sequence variants in the human 25-hydroxyvitamin D3 1-alpha-hydroxylase (CYP27B1) gene are not associated with prostate cancer risk.
The Prostate 2002;53(3):175-8.
2002: Walsh Patrick C
Intravenous zoledronic acid in postmenopausal women with low bone mineral density.
The Journal of urology 2002;168(4 Pt 1):1643.
2002: Walsh Patrick C
The antisteoporotic efficacy of intravenous pamidronate in men with prostate carcinoma receiving combined androgen blockade. A double blind, randomized, placebo-controlled crossover study.
The Journal of urology 2002;168(4 Pt 1):1642-3.
2002: Walsh Patrick C
Variations in morbidity after radical prostatectomy.
The Journal of urology 2002;168(4 Pt 1):1642.
2002: Walsh Patrick C
The association of treatment-related symptoms with quality-of-life outcomes for localized prostate carcinoma patients.
The Journal of urology 2002;168(4 Pt 1):1641.
2002: Walsh Patrick C
Risk of positive margins and biochemical recurrence in relation to nerve-sparing radical prostatectomy.
The Journal of urology 2002;168(4 Pt 1):1641.
2002: Walsh Patrick C
Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging.
The Journal of urology 2002;168(4 Pt 1):1640.
2002: Walsh Patrick C
Large-scale randomized prostate cancer screening trials: program performance in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary Cancer Trial.
The Journal of urology 2002;168(4 Pt 1):1639.
2002: Walsh Patrick C
A prospective study of physical activity and risk of prostate cancer in US physicians.
The Journal of urology 2002;168(4 Pt 1):1638-9.
2002: Walsh Patrick C
Survival of blacks and whites after a cancer diagnosis.
The Journal of urology 2002;168(4 Pt 1):1637-8.
2002: Walsh Patrick C
Risks and benefits of soy phytoestrogens in cardiovascular diseases, cancer, climacteric symptoms and osteoporosis.
The Journal of urology 2002;168(4 Pt 1):1637.
2002: Walsh Patrick C
Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention.
The Journal of urology 2002;168(4 Pt 1):1636-7.
2002: Walsh Patrick C
Associations between hOGG1 sequence variants and prostate cancer susceptibility.
The Journal of urology 2002;168(4 Pt 1):1636.
2002: Walsh Patrick C
Heterogeneity of genetic alterations in prostate cancer: evidence of the complex nature of the disease.
The Journal of urology 2002;168(4 Pt 1):1635-6.
2002: Walsh Patrick C
Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.
The Journal of urology 2002;168(4 Pt 1):1635.
2002: Walsh Patrick C
Incidence and mortality of testicular and prostatic cancers in relation to world dietary practices.
The Journal of urology 2002;168(4 Pt 1):1634, 1635.
2002: Walsh Patrick C
A prospective study on the intake of animal products and risk of prostate cancer.
The Journal of urology 2002;168(4 Pt 1):1634, 1635.
2002: Gretzer Matthew B; Trock Bruce J; Han Misop; Walsh Patrick C
A critical analysis of the interpretation of biochemical failure in surgically treated patients using the American Society for Therapeutic Radiation and Oncology criteria.
The Journal of urology 2002;168(4 Pt 1):1419-22.
2002: Xu Jianfeng; Zheng S Lilly; Komiya Akira; Mychaleckyj Josyf C; Isaacs Sarah D; Hu Jennifer J; Sterling David; Lange Ethan M; Hawkins Gregory A; Turner Aubrey; Ewing Charles M; Faith Dennis A; Johnson Jill R; Suzuki Hiroyoshi; Bujnovszky Piroska; Wiley Kathleen E; DeMarzo Angelo M; Bova G Steven; Chang Baoli; Hall M Craig; McCullough David L; Partin Alan W; Kassabian Vahan S; Carpten John D; Bailey-Wilson Joan E; Trent Jeffrey M; Ohar Jill; Bleecker Eugene R; Walsh Patrick C; Isaacs William B; Meyers Deborah A
Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk.
Nature genetics 2002;32(2):321-5.
2002: Walsh Patrick C
Surgery and the reduction of mortality from prostate cancer.
The New England journal of medicine 2002;347(11):839-40.
2002: Hawkins Gregory A; Mychaleckyj Josyf C; Zheng Siqun L; Faith Dennis A; Kelly Brian; Isaacs S D; Wiley Kathleen E; Chang Bao-Li; Ewing Charles M; Bujnovszky Piroska; Bleecker Eugene R; Walsh P C; Meyers Deborah A; Isaacs William B; Xu Jianfeng
Germline sequence variants of the LZTS1 gene are associated with prostate cancer risk.
Cancer genetics and cytogenetics 2002;137(1):1-7.
2002: Walsh Patrick C; Marschke Penny L
Intussusception of the reconstructed bladder neck leads to earlier continence after radical prostatectomy.
Urology 2002;59(6):934-8.
2002: Xu Jianfeng; Zheng Siqun L; Turner Aubrey; Isaacs Sarah D; Wiley Kathy E; Hawkins Gregory A; Chang Bao-li; Bleecker Eugene R; Walsh Patrick C; Meyers Deborah A; Isaacs William B
Associations between hOGG1 sequence variants and prostate cancer susceptibility.
Cancer research 2002;62(8):2253-7.
2002: Ho Gloria Y F; Knapp Michael; Freije Diha; Nelson William G; Smith Jeffrey R; Carpten John D; Bailey-Wilson Joan E; Beaty Terri H; Petersen Gloria; Xu Jianfeng; Kamensky Victor; Walsh Patrick C; Isaacs William B
Transmission/disequilibrium tests of androgen receptor and glutathione S-transferase pi variants in prostate cancer families.
International journal of cancer. Journal international du cancer 2002;98(6):938-42.
2002: Chang Bao-li; Zheng Siqun L; Hawkins Gregory A; Isaacs Sarah D; Wiley Kathy E; Turner Aubrey; Carpten John D; Bleecker Eugene R; Walsh Patrick C; Trent Jeffrey M; Meyers Deborah A; Isaacs William B; Xu Jianfeng
Joint effect of HSD3B1 and HSD3B2 genes is associated with hereditary and sporadic prostate cancer susceptibility.
Cancer research 2002;62(6):1784-9.
2002: Carter H Ballentine; Walsh Patrick C; Landis Patricia; Epstein Jonathan I
Expectant management of nonpalpable prostate cancer with curative intent: preliminary results.
The Journal of urology 2002;167(3):1231-4.
2002: Chang Bao-li; Zheng Siqun L; Hawkins Gregory A; Isaacs Sarah D; Wiley Kathy E; Turner Aubrey; Carpten John D; Bleecker Eugene R; Walsh Patrick C; Trent Jeffrey M; Meyers Deborah A; Isaacs William B; Xu Jianfeng
Polymorphic GGC repeats in the androgen receptor gene are associated with hereditary and sporadic prostate cancer risk.
Human genetics 2002;110(2):122-9.
2002: Gormley Gleen J; Stoner Elizabeth; Bruskewitz Reginald C; Imperato-McGinley Julianne; Walsh Patrick C; McConnell John D; Andriole Gerald L; Geller Jack; Bracken Bruce R; Tenover Joyce S; Vaughan E Darracott; Pappas Frances; Taylor Alice; Binkowitz Bruce; Ng Jennifer;
The effect of finasteride in men with benign prostatic hyperplasia. 1992.
The Journal of urology 2002;167(2 Pt 2):1102-7; discussion 1108.
2002: Walsh Patrick C; Donker Pieter J
Impotence following radical prostatectomy: insight into etiology and prevention. 1982.
The Journal of urology 2002;167(2 Pt 2):1005-10.
2002: O'Malley Kiaran J; Pound Charles R; Walsh Patrick C; Epstein Jonathan I; Partin Alan W
Influence of biopsy perineural invasion on long-term biochemical disease-free survival after radical prostatectomy.
Urology 2002;59(1):85-90.
2001: Partin A W; Mangold L A; Lamm D M; Walsh P C; Epstein J I; Pearson J D
Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium.
Urology 2001;58(6):843-8.
2001: Walsh P C
Re: High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized cancer.
The Journal of urology 2001;166(6):2321-2.
2001: Barocas D A; Han M; Epstein J I; Chan D Y; Trock B J; Walsh P C; Partin A W
Does capsular incision at radical retropubic prostatectomy affect disease-free survival in otherwise organ-confined prostate cancer?
Urology 2001;58(5):746-51.
2001: Chang B; Zheng S L; Isaacs S D; Wiley K E; Carpten J D; Hawkins G A; Bleecker E R; Walsh P C; Trent J M; Meyers D A; Isaacs W B; Xu J
Linkage and association of CYP17 gene in hereditary and sporadic prostate cancer.
International journal of cancer. Journal international du cancer 2001;95(6):354-9.
2001: Epstein J I; Walsh P C; Carter H B
Dedifferentiation of prostate cancer grade with time in men followed expectantly for stage T1c disease.
The Journal of urology 2001;166(5):1688-91.
2001: Walsh P
The role of external beam radiotherapy with I-125/Pd-103 brachytherapy for prostate carcinoma.
The Journal of urology 2001;166(4):1581-2.
2001: Han M; Partin A W; Pound C R; Epstein J I; Walsh P C
Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience.
The Urologic clinics of North America 2001;28(3):555-65.
2001: Walsh P C; DeWeese T L; Eisenberger M A
A structured debate: immediate versus deferred androgen suppression in prostate cancer-evidence for deferred treatment.
The Journal of urology 2001;166(2):508-15; discussion 515-6.
2001: Han M; Partin A W; Piantadosi S; Epstein J I; Walsh P C
Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer.
The Journal of urology 2001;166(2):416-9.
2001: Xu J; Zheng S L; Hawkins G A; Faith D A; Kelly B; Isaacs S D; Wiley K E; Chang B; Ewing C M; Bujnovszky P; Carpten J D; Bleecker E R; Walsh P C; Trent J M; Meyers D A; Isaacs W B
Linkage and association studies of prostate cancer susceptibility: evidence for linkage at 8p22-23.
American journal of human genetics 2001;69(2):341-50.
2001: Epstein J I; Walsh P C; Carter H B
Importance of posterolateral needle biopsies in the detection of prostate cancer.
Urology 2001;57(6):1112-6.
2001: Roberts W W; Bergstralh E J; Blute M L; Slezak J M; Carducci M; Han M; Epstein J I; Eisenberger M A; Walsh P C; Partin A W
Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomy.
Urology 2001;57(6):1033-7.
2001: Walsh P C
Nerve grafts are rarely necessary and are unlikely to improve sexual function in men undergoing anatomic radical prostatectomy.
Urology 2001;57(6):1020-4.
2001: Zheng S L; Xu J; Isaacs S D; Wiley K; Chang B; Bleecker E R; Walsh P C; Trent J M; Meyers D A; Isaacs W B
Evidence for a prostate cancer linkage to chromosome 20 in 159 hereditary prostate cancer families.
Human genetics 2001;108(5):430-5.
2001: Xu J; Zheng S L; Chang B; Smith J R; Carpten J D; Stine O C; Isaacs S D; Wiley K E; Henning L; Ewing C; Bujnovszky P; Bleeker E R; Walsh P C; Trent J M; Meyers D A; Isaacs W B
Linkage of prostate cancer susceptibility loci to chromosome 1.
Human genetics 2001;108(4):335-45.
2001: Carter H B; Landis P K; Epstein J I; Walsh P C
Expectant management of prostate cancer with curative intent.
European urology 2001;39 Suppl 4():24.
2001: Han M; Piantadosi S; Zahurak M L; Sokoll L J; Chan D W; Epstein J I; Walsh P C; Partin A W
Serum acid phosphatase level and biochemical recurrence following radical prostatectomy for men with clinically localized prostate cancer.
Urology 2001;57(4):707-11.
2001: Xu J; Zheng S L; Carpten J D; Nupponen N N; Robbins C M; Mestre J; Moses T Y; Faith D A; Kelly B D; Isaacs S D; Wiley K E; Ewing C M; Bujnovszky P; Chang B; Bailey-Wilson J; Bleecker E R; Walsh P C; Trent J M; Meyers D A; Isaacs W B
Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer.
American journal of human genetics 2001;68(4):901-11.
2001: Walsh P C; Marschke P; Catalona W J; Lepor H; Martin S; Myers R P; Steiner M S
Efficacy of first-generation Cavermap to verify location and function of cavernous nerves during radical prostatectomy: a multi-institutional evaluation by experienced surgeons.
Urology 2001;57(3):491-4.
2001: Walsh P C
Re: Radical prostatectomy: the value of preoperative, individually labeled apical biopsies.
The Journal of urology 2001;165(3):915.
2001: Han M; Pound C R; Potter S R; Partin A W; Epstein J I; Walsh P C
Isolated local recurrence is rare after radical prostatectomy in men with Gleason 7 prostate cancer and positive surgical margins: therapeutic implications.
The Journal of urology 2001;165(3):864-6.
2001: Walsh P C
Modern prostate brachytherapy: prostate specific antigen results in 219 patients with up to 12 years of observed follow-up.
The Journal of urology 2001;165(1):318-9.
2000: Potter S R; Mangold L A; Shue M J; Taylor D C; Lecksell K L; Epstein J I; Walsh P C; Partin A W
Molecular and immunohistochemical staging of men with seminal vesicle invasion and negative pelvic lymph nodes at radical prostatectomy.
Cancer 2000;89(12):2577-86.
2000: Han M; Snow P B; Epstein J I; Chan T Y; Jones K A; Walsh P C; Partin A W
A neural network predicts progression for men with gleason score 3+4 versus 4+3 tumors after radical prostatectomy.
Urology 2000;56(6):994-9.
2000: Bahnson R R; Hanks G E; Huben R P; Kantoff P; Kozlowski J M; Kuettel M; Lange P H; Logothetis C; Pow-Sang J M; Roach M; Sandler H; Scardino P T; Taylor R J; Urban D A; Walsh P C; Wilson T G;
NCCN Practice Guidelines for Prostate Cancer.
Oncology (Williston Park, N.Y.) 2000;14(11A):111-9.
2000: Feneley M R; Landis P; Simon I; Metter E J; Morrell C H; Carter H B; Walsh P C
Today men with prostate cancer have larger prostates.
Urology 2000;56(5):839-42.
2000: Chan T Y; Partin A W; Walsh P C; Epstein J I
Prognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prostatectomy.
Urology 2000;56(5):823-7.
2000: Blute M L; Bergstralh E J; Partin A W; Walsh P C; Kattan M W; Scardino P T; Montie J E; Pearson J D; Slezak J M; Zincke H
Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer.
The Journal of urology 2000;164(5):1591-5.
2000: Walsh P C
Re: radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer.
The Journal of urology 2000;164(4):1322-3.
2000: Epstein J I; Partin A W; Potter S R; Walsh P C
Adenocarcinoma of the prostate invading the seminal vesicle: prognostic stratification based on pathologic parameters.
Urology 2000;56(2):283-8.
2000: Catalona W J; Southwick P C; Slawin K M; Partin A W; Brawer M K; Flanigan R C; Patel A; Richie J P; Walsh P C; Scardino P T; Lange P H; Gasior G H; Loveland K G; Bray K R
Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging.
Urology 2000;56(2):255-60.
2000: Walsh P C
Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer.
The Journal of urology 2000;164(1):246-7.
2000: Walsh P C
Patient-reported urinary continence and sexual function after anatomic radical prostatectomy.
The Journal of urology 2000;164(1):242.
2000: Han M; Walsh P C; Partin A W; Rodriguez R
Ability of the 1992 and 1997 American Joint Committee on Cancer staging systems for prostate cancer to predict progression-free survival after radical prostatectomy for stage T2 disease.
The Journal of urology 2000;164(1):89-92.
2000: Rodriguez R; Walsh P C
Trousseau's syndrome in a patient with metastatic prostate cancer.
The Journal of urology 2000;163(6):1877.
2000: Walsh P C
Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life: a structured debate.
The Journal of urology 2000;163(6):1802-7.
2000: Catalona W J; Partin A W; Slawin K M; Naughton C K; Brawer M K; Flanigan R C; Richie J P; Patel A; Walsh P C; Scardino P T; Lange P H; deKernion J B; Southwick P C; Loveland K G; Parson R E; Gasior G H
Percentage of free PSA in black versus white men for detection and staging of prostate cancer: a prospective multicenter clinical trial.
Urology 2000;55(3):372-6.
2000: Walsh P C; Marschke P; Ricker D; Burnett A L
Use of intraoperative video documentation to improve sexual function after radical retropubic prostatectomy.
Urology 2000;55(1):62-7.
2000: Walsh P C; Marschke P; Ricker D; Burnett A L
Patient-reported urinary continence and sexual function after anatomic radical prostatectomy.
Urology 2000;55(1):58-61.
2000: Walsh P C
Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE.
The Journal of urology 2000;163(1):370.
2000: Walsh P C
Cancer surveillance series: interpreting trends in prostate cancer--part I: evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.
The Journal of urology 2000;163(1):364-5.
1999: Eisenberger M A; Walsh P C
Early androgen deprivation for prostate cancer?
The New England journal of medicine 1999;341(24):1837-8.
1999: Epstein J I; Walsh P C; Akingba G; Carter H B
The significance of prior benign needle biopsies in men subsequently diagnosed with prostate cancer.
The Journal of urology 1999;162(5):1649-52.
1999: Southwick P C; Catalona W J; Partin A W; Slawin K M; Brawer M K; Flanigan R C; Patel A; Richie J P; Walsh P C; Scardino P T; Lange P H; Gasior G H; Parson R E; Loveland K G
Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen: a prospective multicenter clinical trial.
The Journal of urology 1999;162(4):1346-51.
1999: Pound C R; Christens-Barry O W; Gurganus R T; Partin A W; Walsh P C
Digital rectal examination and imaging studies are unnecessary in men with undetectable prostate specific antigen following radical prostatectomy.
The Journal of urology 1999;162(4):1337-40.
1999: Feneley M R; Walsh P C
Incontinence after radical prostatectomy.
Lancet 1999;353(9170):2091-2.
1999: Wilkens E P; Freije D; Xu J; Nusskern D R; Suzuki H; Isaacs S D; Wiley K; Bujnovsky P; Meyers D A; Walsh P C; Isaacs W B
No evidence for a role of BRCA1 or BRCA2 mutations in Ashkenazi Jewish families with hereditary prostate cancer.
The Prostate 1999;39(4):280-4.
1999: Pound C R; Partin A W; Eisenberger M A; Chan D W; Pearson J D; Walsh P C
Natural history of progression after PSA elevation following radical prostatectomy.
JAMA : the journal of the American Medical Association 1999;281(17):1591-7.
1999: Holmes G F; Walsh P C; Pound C R; Epstein J I
Excision of the neurovascular bundle at radical prostatectomy in cases with perineural invasion on needle biopsy.
Urology 1999;53(4):752-6.
1999: Walsh P C
Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high gleason grade prostate carcinoma.
The Journal of urology 1999;161(1):357-8.
1999: Walsh P C
Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial.
The Journal of urology 1999;161(1):350-1.
1999: Eisenberger C F; Walsh P C; Eisenberger M A; Chow N H; Partin A W; Mostwin J L; Marshall F F; Epstein J I; Schoenberg M
Incidental non-Hodgkin's lymphoma in patients with localized prostate cancer.
Urology 1999;53(1):175-9.
1998: Walsh P C
Anatomic radical prostatectomy: evolution of the surgical technique.
The Journal of urology 1998;160(6 Pt 2):2418-24.
1998: Epstein J I; Chan D W; Sokoll L J; Walsh P C; Cox J L; Rittenhouse H; Wolfert R; Carter H B
Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings.
The Journal of urology 1998;160(6 Pt 2):2407-11.
1998: Argani P; Walsh P C; Epstein J I
Analysis of the prostatic central zone in patients with unilateral absence of wolffian duct structures: further evidence of the mesodermal origin of the prostatic central zone.
The Journal of urology 1998;160(6 Pt 1):2126-9.
1998: Xu J; Meyers D; Freije D; Isaacs S; Wiley K; Nusskern D; Ewing C; Wilkens E; Bujnovszky P; Bova G S; Walsh P; Isaacs W; Schleutker J; Matikainen M; Tammela T; Visakorpi T; Kallioniemi O P; Berry R; Schaid D; French A; McDonnell S; Schroeder J; Blute M; Thibodeau S; Grönberg H; Emanuelsson M; Damber J E; Bergh A; Jonsson B A; Smith J; Bailey-Wilson J; Carpten J; Stephan D; Gillanders E; Amundson I; Kainu T; Freas-Lutz D; Baffoe-Bonnie A; Van Aucken A; Sood R; Collins F; Brownstein M; Trent J
Evidence for a prostate cancer susceptibility locus on the X chromosome.
Nature genetics 1998;20(2):175-9.
1998: Glover F E; Coffey D S; Douglas L L; Russell H; Cadigan M; Tulloch T; Wedderburn K; Wan R L; Baker T D; Walsh P C
Familial study of prostate cancer in Jamaica.
Urology 1998;52(3):441-3.
1998: Bova G S; Partin A W; Isaacs S D; Carter B S; Beaty T L; Isaacs W B; Walsh P C
Biological aggressiveness of hereditary prostate cancer: long-term evaluation following radical prostatectomy.
The Journal of urology 1998;160(3 Pt 1):660-3.
1998: Miller L R; Partin A W; Chan D W; Bruzek D J; Dobs A S; Epstein J I; Walsh P C
Influence of radical prostatectomy on serum hormone levels.
The Journal of urology 1998;160(2):449-53.
1998: Walsh P C
Intermittent androgen deprivation for clinically localized prostate cancer: initial experience.
The Journal of urology 1998;160(1):270-1.
1998: Walsh P C
Early age at diagnosis in families providing evidence of linkage to the hereditary prostate cancer locus (HPC1) on chromosome 1.
The Journal of urology 1998;160(1):265-6.
1998: Epstein J I; Pound C R; Partin A W; Walsh P C
Disease progression following radical prostatectomy in men with Gleason score 7 tumor.
The Journal of urology 1998;160(1):97-100; discussion 101.
1998: Polascik T J; Pound C R; DeWeese T L; Walsh P C
Comparison of radical prostatectomy and iodine 125 interstitial radiotherapy for the treatment of clinically localized prostate cancer: a 7-year biochemical (PSA) progression analysis.
Urology 1998;51(6):884-9; discussion 889-90.
1998: Glover F E; Coffey D S; Douglas L L; Cadogan M; Russell H; Tulloch T; Baker T D; Wan R L; Walsh P C
The epidemiology of prostate cancer in Jamaica.
The Journal of urology 1998;159(6):1984-6; discussion 1986-7.
1998: Catalona W J; Partin A W; Slawin K M; Brawer M K; Flanigan R C; Patel A; Richie J P; deKernion J B; Walsh P C; Scardino P T; Lange P H; Subong E N; Parson R E; Gasior G H; Loveland K G; Southwick P C
Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial.
JAMA : the journal of the American Medical Association 1998;279(19):1542-7.
1998: Pannek J; Rittenhouse H G; Chan D W; Epstein J I; Walsh P C; Partin A W
The use of percent free prostate specific antigen for staging clinically localized prostate cancer.
The Journal of urology 1998;159(4):1238-42.
1998: Walsh P C
Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy.
The Journal of urology 1998;159(1):308-9.
1998: Cadeddu J A; Partin A W; DeWeese T L; Walsh P C
Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy.
The Journal of urology 1998;159(1):173-7; discussion 177-8.
1997: Walsh P C
Conflict of interest or widely held misconception?
Urology 1997;50(6):1028.
1997: Page W F; Braun M M; Partin A W; Caporaso N; Walsh P
Heredity and prostate cancer: a study of World War II veteran twins.
The Prostate 1997;33(4):240-5.
1997: Grönberg H; Xu J; Smith J R; Carpten J D; Isaacs S D; Freije D; Bova G S; Danber J E; Bergh A; Walsh P C; Collins F S; Trent J M; Meyers D A; Isaacs W B
Early age at diagnosis in families providing evidence of linkage to the hereditary prostate cancer locus (HPC1) on chromosome 1.
Cancer research 1997;57(21):4707-9.
1997: Walsh P C; Partin A W
Family history facilitates the early diagnosis of prostate carcinoma.
Cancer 1997;80(9):1871-4.
1997: Epstein J I; Walsh P C; Sauvageot J; Carter H B
Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer.
The Journal of urology 1997;158(5):1886-90.
1997: Grönberg H; Isaacs S D; Smith J R; Carpten J D; Bova G S; Freije D; Xu J; Meyers D A; Collins F S; Trent J M; Walsh P C; Isaacs W B
Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus.
JAMA : the journal of the American Medical Association 1997;278(15):1251-5.
1997: Walsh P C
Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial. The Medical Research Council Prostate Cancer Working Party Investigators Group.
The Journal of urology 1997;158(4):1623-4.
1997: Walsh P C
Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: a multi-institutional update.
The Journal of urology 1997;158(4):1618-9.
1997: Walsh P C
Screening for prostate cancer. American College of Physicians.
The Journal of urology 1997;158(4):1617.
1997: Cadeddu J A; Partin A W; Epstein J I; Walsh P C
Stage D1 (T1-3, N1-3, M0) prostate cancer: a case-controlled comparison of conservative treatment versus radical prostatectomy.
Urology 1997;50(2):251-5.
1997: Carter H B; Sauvageot J; Walsh P C; Epstein J I
Prospective evaluation of men with stage T1C adenocarcinoma of the prostate.
The Journal of urology 1997;157(6):2206-9.
1997: Thiel R; Pearson J D; Epstein J I; Walsh P C; Carter H B
Role of prostate-specific antigen velocity in prediction of final pathologic stage in men with localized prostate cancer.
Urology 1997;49(5):716-20.
1997: Partin A W; Kattan M W; Subong E N; Walsh P C; Wojno K J; Oesterling J E; Scardino P T; Pearson J D
Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update.
JAMA : the journal of the American Medical Association 1997;277(18):1445-51.
1997: Pound C R; Partin A W; Epstein J I; Walsh P C
Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control.
The Urologic clinics of North America 1997;24(2):395-406.
1997: Walsh P C
Localized prostate cancer-mortality and morbidity.
The Journal of urology 1997;157(5):1773.
1997: Walsh P C
Is prostate cancer screening analogous to lung cancer screening?
JAMA : the journal of the American Medical Association 1997;277(14):1121; author reply 1121-2.
1997: Walsh P C
Re: Randomized, prospective, controlled study comparing radical prostatectomy alone and neoadjuvant androgen withdrawal in the treatment of localized prostate cancer.
The Journal of urology 1997;157(3):965.
1997: Sanda M G; Doehring C B; Binkowitz B; Beaty T H; Partin A W; Hale E; Stoner E; Walsh P C
Clinical and biological characteristics of familial benign prostatic hyperplasia.
The Journal of urology 1997;157(3):876-9.
1997: Walsh P C; Brooks J D
The Swedish prostate cancer paradox.
JAMA : the journal of the American Medical Association 1997;277(6):497-8.
1997: Pound C R; Walsh P C; Epstein J I; Chan D W; Partin A W
Radical prostatectomy as treatment for prostate-specific antigen-detected stage T1c prostate cancer.
World journal of urology 1997;15(6):373-7.
1996: Baker L H; Hanks G; Gershenson D; Kantoff P; Lange P; Logothetis C; Sandler H; Walsh P
NCCN Prostate Cancer Practice Guidelines. The National Comprehensive Cancer Network.
Oncology (Williston Park, N.Y.) 1996;10(11 Suppl):265-88.
1996: Smith J R; Freije D; Carpten J D; Grönberg H; Xu J; Isaacs S D; Brownstein M J; Bova G S; Guo H; Bujnovszky P; Nusskern D R; Damber J E; Bergh A; Emanuelsson M; Kallioniemi O P; Walker-Daniels J; Bailey-Wilson J E; Beaty T H; Meyers D A; Walsh P C; Collins F S; Trent J M; Isaacs W B
Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search.
Science (New York, N.Y.) 1996;274(5291):1371-4.
1996: Doehring C B; Sanda M G; Partin A W; Sauvageot J; Juo H; Beaty T H; Epstein J I; Hill G; Walsh P C
Histopathologic characterization of hereditary benign prostatic hyperplasia.
Urology 1996;48(4):650-3.
1996: Walsh P C
Treatment of benign prostatic hyperplasia.
The New England journal of medicine 1996;335(8):586-7.
1996: Niesel T; Partin A W; Walsh P C
Anatomic approach for placement of surgical drains after radical retropubic prostatectomy: long-term effects on postoperative pain.
Urology 1996;48(1):91-4.
1996: Epstein J I; Walsh P C; Sanfilippo F
Clinical and cost impact of second-opinion pathology. Review of prostate biopsies prior to radical prostatectomy.
The American journal of surgical pathology 1996;20(7):851-7.
1996: Walsh P C
Follow-up prostate cancer treatments after radical prostatectomy: a population-based study.
The Journal of urology 1996;156(1):301-2.
1996: Walsh P C
The definition and preoperative prediction of clinically insignificant prostate cancer.
The Journal of urology 1996;156(1):300-1.
1996: Walsh P C
Re: Quality of life: radical prostatectomy versus radiation therapy for prostate cancer.
The Journal of urology 1996;155(6):2038-9.
1996: Walsh P C
RE: Prostate specific antigen after gonadal androgen withdrawal and deferred flutamide treatment.
The Journal of urology 1996;155(5):1705.
1996: Partin A W; Criley S R; Subong E N; Zincke H; Walsh P C; Oesterling J E
Standard versus age-specific prostate specific antigen reference ranges among men with clinically localized prostate cancer: A pathological analysis.
The Journal of urology 1996;155(4):1336-9.
1996: Epstein J I; Partin A W; Sauvageot J; Walsh P C
Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up.
The American journal of surgical pathology 1996;20(3):286-92.
1996: Schoenberg M; Kiemeney L; Walsh P C; Griffin C A; Sidransky D
Germline translocation t(5;20)(p15;q11) and familial transitional cell carcinoma.
The Journal of urology 1996;155(3):1035-6.
1996: Schoenberg M P; Walsh P C; Breazeale D R; Marshall F F; Mostwin J L; Brendler C B
Local recurrence and survival following nerve sparing radical cystoprostatectomy for bladder cancer: 10-year followup.
The Journal of urology 1996;155(2):490-4.
1996: Walsh P C
Re: Potency-sparing radical retropubic prostatectomy: a simplified anatomical approach.
The Journal of urology 1996;155(1):294.
1995: Quinlan D M; Partin A W; Walsh P C
Can aggressive prostatic carcinomas be identified and can their natural history be altered by treatment?
Urology 1995;46(3 Suppl A):77-82.
1995: Polascik T J; Walsh P C
Radical retropubic prostatectomy: the influence of accessory pudendal arteries on the recovery of sexual function.
The Journal of urology 1995;154(1):150-2.
1995: Isaacs S D; Kiemeney L A; Baffoe-Bonnie A; Beaty T H; Walsh P C
Risk of cancer in relatives of prostate cancer probands.
Journal of the National Cancer Institute 1995;87(13):991-6.
1995: Carter H B; Pearson J D; Metter E J; Chan D W; Andres R; Fozard J L; Rosner W; Walsh P C
Longitudinal evaluation of serum androgen levels in men with and without prostate cancer.
The Prostate 1995;27(1):25-31.
1995: Walsh P C
A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia.
The Journal of urology 1995;154(1):301.
1995: Berges R R; Vukanovic J; Epstein J I; CarMichel M; Cisek L; Johnson D E; Veltri R W; Walsh P C; Isaacs J T
Implication of cell kinetic changes during the progression of human prostatic cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(5):473-80.
1995: Partin A W; Piantadosi S; Sanda M G; Epstein J I; Marshall F F; Mohler J L; Brendler C B; Walsh P C; Simons J W
Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy.
Urology 1995;45(5):831-8.
1995: Carter H B; Pearson J D; Waclawiw Z; Metter E J; Chan D W; Guess H A; Walsh P C
Prostate-specific antigen variability in men without prostate cancer: effect of sampling interval on prostate-specific antigen velocity.
Urology 1995;45(4):591-6.
1995: Bastacky S I; Wojno K J; Walsh P C; Carmichael M J; Epstein J I
Pathological features of hereditary prostate cancer.
The Journal of urology 1995;153(3 Pt 2):987-92.
1995: Carmichael M J; Veltri R W; Partin A W; Miller M C; Walsh P C; Epstein J I
Deoxyribonucleic acid ploidy analysis as a predictor of recurrence following radical prostatectomy for stage T2 disease.
The Journal of urology 1995;153(3 Pt 2):1015-9.
1994: Walsh P C
The status of radical prostatectomy in the United States in 1993: where do we go from here?
The Journal of urology 1994;152(5 Pt 2):1816.
1994: Partin A W; Page W F; Lee B R; Sanda M G; Miller R N; Walsh P C
Concordance rates for benign prostatic disease among twins suggest hereditary influence.
Urology 1994;44(5):646-50.
1994: Walsh P C; Partin A W; Epstein J I
Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years.
The Journal of urology 1994;152(5 Pt 2):1831-6.
1994: Epstein J I; Walsh P C; Brendler C B
Radical prostatectomy for impalpable prostate cancer: the Johns Hopkins experience with tumors found on transurethral resection (stages T1A and T1B) and on needle biopsy (stage T1C).
The Journal of urology 1994;152(5 Pt 2):1721-9.
1994: Hedican S P; Walsh P C
Postoperative bleeding following radical retropubic prostatectomy.
The Journal of urology 1994;152(4):1181-3.
1994: Sgrignoli A R; Walsh P C; Steinberg G D; Steiner M S; Epstein J I
Prognostic factors in men with stage D1 prostate cancer: identification of patients less likely to have prolonged survival after radical prostatectomy.
The Journal of urology 1994;152(4):1077-81.
1994: Walsh P C
Radical prostatectomy: a procedure in evolution.
Seminars in oncology 1994;21(5):662-71.
1994: Walsh P C
Prostate cancer kills: strategy to reduce deaths.
Urology 1994;44(4):463-6.
1994: Walsh P C
Results of conservative management of clinically localized prostate cancer.
The Journal of urology 1994;152(1):255-6.
1994: Partin A W; Walsh P C
Re: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer.
The Journal of urology 1994;152(1):172-3.
1994: Sanda M G; Beaty T H; Stutzman R E; Childs B; Walsh P C
Genetic susceptibility of benign prostatic hyperplasia.
The Journal of urology 1994;152(1):115-9.
1994: Epstein J I; Carmichael M J; Partin A W; Walsh P C
Small high grade adenocarcinoma of the prostate in radical prostatectomy specimens performed for nonpalpable disease: pathogenetic and clinical implications.
The Journal of urology 1994;151(6):1587-92.
1994: Partin A W; Lee B R; Carmichael M; Walsh P C; Epstein J I
Radical prostatectomy for high grade disease: a reevaluation 1994.
The Journal of urology 1994;151(6):1583-6.
1994: Partin A W; Pearson J D; Landis P K; Carter H B; Pound C R; Clemens J Q; Epstein J I; Walsh P C
Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases.
Urology 1994;43(5):649-59.
1994: Epstein J I; Walsh P C; Carmichael M; Brendler C B
Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer.
JAMA : the journal of the American Medical Association 1994;271(5):368-74.
1994: Schoenberg M P; Hakimi J M; Wang S; Bova G S; Epstein J I; Fischbeck K H; Isaacs W B; Walsh P C; Barrack E R
Microsatellite mutation (CAG24-->18) in the androgen receptor gene in human prostate cancer.
Biochemical and biophysical research communications 1994;198(1):74-80.
1994: Walsh P C; Partin A W
Treatment of early stage prostate cancer: radical prostatectomy.
Important advances in oncology 1994;():211-23.
1993: Walsh P C
Using prostate-specific antigen to diagnose prostate cancer: sailing in uncharted waters.
Annals of internal medicine 1993;119(9):948-9.
1993: Partin A W; Pound C R; Clemens J Q; Epstein J I; Walsh P C
Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years.
The Urologic clinics of North America 1993;20(4):713-25.
1993: Walsh P C
A decision analysis of alternative treatment strategies for clinically localized prostate cancer.
The Journal of urology 1993;150(4):1330-2.
1993: Walsh P C
Disease-specific survival following routine prostate cancer screening by digital rectal examination.
The Journal of urology 1993;150(4):1328-9.
1993: Cisek L J; Walsh P C
Thromboembolic complications following radical retropubic prostatectomy. Influence of external sequential pneumatic compression devices.
Urology 1993;42(4):406-8.
1993: Carter B S; Bova G S; Beaty T H; Steinberg G D; Childs B; Isaacs W B; Walsh P C
Hereditary prostate cancer: epidemiologic and clinical features.
The Journal of urology 1993;150(3):797-802.
1993: Bova G S; Carter B S; Bussemakers M J; Emi M; Fujiwara Y; Kyprianou N; Jacobs S C; Robinson J C; Epstein J I; Walsh P C
Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer.
Cancer research 1993;53(17):3869-73.
1993: Burnett A L; Tillman S L; Chang T S; Epstein J I; Lowenstein C J; Bredt D S; Snyder S H; Walsh P C
Immunohistochemical localization of nitric oxide synthase in the autonomic innervation of the human penis.
The Journal of urology 1993;150(1):73-6.
1993: Epstein J I; Carmichael M J; Pizov G; Walsh P C
Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long-term followup.
The Journal of urology 1993;150(1):135-41.
1993: Partin A W; Yoo J; Carter H B; Pearson J D; Chan D W; Epstein J I; Walsh P C
The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer.
The Journal of urology 1993;150(1):110-4.
1993: Epstein J I; Carmichael M; Partin A W; Walsh P C
Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup.
The Journal of urology 1993;149(6):1478-81.
1993: Epstein J I; Pizov G; Walsh P C
Correlation of pathologic findings with progression after radical retropubic prostatectomy.
Cancer 1993;71(11):3582-93.
1993: Epstein J I; Carmichael M; Walsh P C
Adenocarcinoma of the prostate invading the seminal vesicle: definition and relation of tumor volume, grade and margins of resection to prognosis.
The Journal of urology 1993;149(5):1040-5.
1993: Bastacky S I; Walsh P C; Epstein J I
Relationship between perineural tumor invasion on needle biopsy and radical prostatectomy capsular penetration in clinical stage B adenocarcinoma of the prostate.
The American journal of surgical pathology 1993;17(4):336-41.
1993: Quinlan D M; Stutzman R E; Peters C A; Walsh P C
Unilateral nerve-sparing radical prostatectomy and hemicystectomy in management of prostate sarcoma.
Urology 1993;41(4):308-10.
1993: Grass J A; Sakima N T; Valley M; Fischer K; Jackson C; Walsh P; Bourke D L
Assessment of ketorolac as an adjuvant to fentanyl patient-controlled epidural analgesia after radical retropubic prostatectomy.
Anesthesiology 1993;78(4):642-8; discussion 21A.
1993: Walsh P C
The effect of finasteride in men with benign prostatic hyperplasia.
The Journal of urology 1993;149(4):932-3.
1993: Tempany C M; Partin A W; Zerhouni E A; Zinreich S J; Walsh P C
The influence of finasteride on the volume of the peripheral and periurethral zones of the prostate in men with benign prostatic hyperplasia.
The Prostate 1993;22(1):39-42.
1992: Burnett A L; Chan D W; Brendler C B; Walsh P C
The value of serum enzymatic acid phosphatase in the staging of localized prostate cancer.
The Journal of urology 1992;148(6):1832-4.
1992: Rahmouni A; Yang A; Tempany C M; Frenkel T; Epstein J; Walsh P; Leichner P K; Ricci C; Zerhouni E
Accuracy of in-vivo assessment of prostatic volume by MRI and transrectal ultrasonography.
Journal of computer assisted tomography 1992;16(6):935-40.
1992: Gormley G J; Stoner E; Bruskewitz R C; Imperato-McGinley J; Walsh P C; McConnell J D; Andriole G L; Geller J; Bracken B R; Tenover J S
The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group.
The New England journal of medicine 1992;327(17):1185-91.
1992: Brendler C B; Walsh P C
The role of radical prostatectomy in the treatment of prostate cancer.
CA: a cancer journal for clinicians 1992;42(4):212-22.
1992: Epstein J I; Pizov G; Steinberg G D; Carter H B; Pitcock R; Armas O A; Partin A; Walsh P C
Correlation of prostate cancer nuclear deoxyribonucleic acid, size, shape and Gleason grade with pathological stage at radical prostatectomy.
The Journal of urology 1992;148(1):87-91.
1992: Carter H B; Morrell C H; Pearson J D; Brant L J; Plato C C; Metter E J; Chan D W; Fozard J L; Walsh P C
Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease.
Cancer research 1992;52(12):3323-8.
1992: Carter B S; Beaty T H; Steinberg G D; Childs B; Walsh P C
Mendelian inheritance of familial prostate cancer.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(8):3367-71.
1992: Carter H B; Pearson J D; Metter E J; Brant L J; Chan D W; Andres R; Fozard J L; Walsh P C
Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease.
JAMA : the journal of the American Medical Association 1992;267(16):2215-20.
1992: Ness P M; Bourke D L; Walsh P C
A randomized trial of perioperative hemodilution versus transfusion of preoperatively deposited autologous blood in elective surgery.
Transfusion 1992;32(3):226-30.
1992: Borland R N; Walsh P C
The management of rectal injury during radical retropubic prostatectomy.
The Journal of urology 1992;147(3 Pt 2):905-7.
1992: Walsh P C
Why make an early diagnosis of prostate cancer.
The Journal of urology 1992;147(3 Pt 2):853-4.
1992: Ness P M; Walsh P C; Zahurak M; Baldwin M L; Piantadosi S
Prostate cancer recurrence in radical surgery patients receiving autologous or homologous blood.
Transfusion 1992;32(1):31-6.
1991: Tempany C M; Rahmouni A D; Epstein J I; Walsh P C; Zerhouni E A
Invasion of the neurovascular bundle by prostate cancer: evaluation with MR imaging.
Radiology 1991;181(1):107-12.
1991: Burgers J K; Nelson R J; Quinlan D M; Walsh P C
Nerve growth factor, nerve grafts and amniotic membrane grafts restore erectile function in rats.
The Journal of urology 1991;146(2):463-8.
1991: Hamper U M; Sheth S; Walsh P C; Holtz P M; Epstein J I
Stage B adenocarcinoma of the prostate: transrectal US and pathologic correlation of nonmalignant hypoechoic peripheral zone lesions.
Radiology 1991;180(1):101-4.
1991: Sadi M V; Walsh P C; Barrack E R
Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy.
Cancer 1991;67(12):3057-64.
1991: Morton R A; Steiner M S; Walsh P C
Cancer control following anatomical radical prostatectomy: an interim report.
The Journal of urology 1991;145(6):1197-200.
1991: Vaughan E D; Walsh P C
Prostate Health Council.
Urology 1991;37(5):501.
1991: Quinlan D M; Epstein J I; Carter B S; Walsh P C
Sexual function following radical prostatectomy: influence of preservation of neurovascular bundles.
The Journal of urology 1991;145(5):998-1002.
1991: Bastacky S S; Walsh P C; Epstein J I
Needle biopsy associated tumor tracking of adenocarcinoma of the prostate.
The Journal of urology 1991;145(5):1003-7.
1991: Sheth S; Hamper U M; Walsh P C; Holtz P M; Epstein J I
Stage A adenocarcinoma of the prostate: transrectal US and sonographic-pathologic correlation.
Radiology 1991;179(1):35-9.
1991: Christensen W N; Steinberg G; Walsh P C; Epstein J I
Prostatic duct adenocarcinoma. Findings at radical prostatectomy.
Cancer 1991;67(8):2118-24.
1991: Steiner M S; Morton R A; Walsh P C
Impact of anatomical radical prostatectomy on urinary continence.
The Journal of urology 1991;145(3):512-4; discussion 514-5.
1991: Marshall F F; Mostwin J L; Radebaugh L C; Walsh P C; Brendler C B
Ileocolic neobladder post-cystectomy: continence and potency.
The Journal of urology 1991;145(3):502-4.
1991: Hamper U M; Sheth S; Walsh P C; Holtz P M; Epstein J I
Capsular transgression of prostatic carcinoma: evaluation with transrectal US with pathologic correlation.
Radiology 1991;178(3):791-5.
1991: Weber J P; Walsh P C; Peters C A; Spivak J L
Effect of reversible androgen deprivation on hemoglobin and serum immunoreactive erythropoietin in men.
American journal of hematology 1991;36(3):190-4.
1991: Quinlan D M; Nelson R J; Walsh P C
Cavernous nerve grafts restore erectile function in denervated rats.
The Journal of urology 1991;145(2):380-3.
1991: Carter H B; Brem R F; Tempany C M; Yang A; Epstein J I; Walsh P C; Zerhouni E A
Nonpalpable prostate cancer: detection with MR imaging.
Radiology 1991;178(2):523-5.
1991: Partin A W; Oesterling J E; Epstein J I; Horton R; Walsh P C
Influence of age and endocrine factors on the volume of benign prostatic hyperplasia.
The Journal of urology 1991;145(2):405-9.
1991: Carter B S; Steinberg G D; Beaty T H; Childs B; Walsh P C
Familial risk factors for prostate cancer.
Cancer surveys 1991;11():5-13.
1990: Steinberg G D; Epstein J I; Piantadosi S; Walsh P C
Management of stage D1 adenocarcinoma of the prostate: the Johns Hopkins experience 1974 to 1987.
The Journal of urology 1990;144(6):1425-32.
1990: Brendler C B; Steinberg G D; Marshall F F; Mostwin J L; Walsh P C
Local recurrence and survival following nerve-sparing radical cystoprostatectomy.
The Journal of urology 1990;144(5):1137-40; discussion 1140-1.
1990: Hamper U M; Sheth S; Walsh P C; Holtz P M; Epstein J I
Carcinoma of the prostate: value of transrectal sonography in detecting extension into the neurovascular bundle.
AJR. American journal of roentgenology 1990;155(5):1015-9.
1990: Carter H B; Partin A W; Epstein J I; Chan D W; Walsh P C
The relationship of prostate specific antigen levels and residual tumor volume in stage A prostate cancer.
The Journal of urology 1990;144(5):1167-70; discussion 1170-1.
1990: Rifkin M D; Zerhouni E A; Gatsonis C A; Quint L E; Paushter D M; Epstein J I; Hamper U; Walsh P C; McNeil B J
Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial.
The New England journal of medicine 1990;323(10):621-6.
1990: Walsh P C; Quinlan D M; Morton R A; Steiner M S
Radical retropubic prostatectomy. Improved anastomosis and urinary continence.
The Urologic clinics of North America 1990;17(3):679-84.
1990: Brendler C B; Schlegel P N; Walsh P C
Urethrectomy with preservation of potency.
The Journal of urology 1990;144(2 Pt 1):270-3.
1990: Hamper U M; Sheth S; Walsh P C; Epstein J I
Bright echogenic foci in early prostatic carcinoma: sonographic and pathologic correlation.
Radiology 1990;176(2):339-43.
1990: Gearhart J P; Donohoue P A; Brown T R; Walsh P C; Berkovitz G D
Endocrine evaluation of adults with mild hypospadias.
The Journal of urology 1990;144(2 Pt 1):274-7.
1990: Coffey D S; Walsh P C
Clinical and experimental studies of benign prostatic hyperplasia.
The Urologic clinics of North America 1990;17(3):461-75.
1990: Hamper U M; Epstein J I; Sheth S; Walsh P C; Sanders R C
Cystic lesions of the prostate gland. A sonographic--pathologic correlation.
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 1990;9(7):395-402.
1990: Walsh P C; Oesterling J E
Improved hemostasis during simple retropubic prostatectomy.
The Journal of urology 1990;143(6):1203-4.
1990: Walsh P C; Brendler C B; Chang T; Marshall F F; Mostwin J I; Stutzman R; Schlegel P N
Preservation of sexual function in men during radical pelvic surgery.
Maryland medical journal (Baltimore, Md. : 1985) 1990;39(4):389-93.
1990: Partin A W; Carter H B; Chan D W; Epstein J I; Oesterling J E; Rock R C; Weber J P; Walsh P C
Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia.
The Journal of urology 1990;143(4):747-52.
1990: Christensen W N; Partin A W; Walsh P C; Epstein J I
Pathologic findings in clinical stage A2 prostate cancer. Relation of tumor volume, grade, and location to pathologic stage.
Cancer 1990;65(4):1021-7.
1990: Walsh P C
Radical prostatectomy in locally confined prostatic carcinoma.
Progress in clinical and biological research 1990;359():199-207; discussion 223-9.
1990: Steinberg G D; Carter B S; Beaty T H; Childs B; Walsh P C
Family history and the risk of prostate cancer.
The Prostate 1990;17(4):337-47.
1990: Walsh P C
Prostate carcinoma-current status and future direction.
Nippon Hinyokika Gakkai zasshi. The japanese journal of urology 1990;81(13 Suppl):1978-9.
1989: Carter H B; Hamper U M; Sheth S; Sanders R C; Epstein J I; Walsh P C
Evaluation of transrectal ultrasound in the early detection of prostate cancer.
The Journal of urology 1989;142(4):1008-10.
1989: Schlegel P N; Walsh P C
The use of the preperitoneal approach for the simultaneous repair of inguinal hernia during surgery on the bladder and prostate.
World journal of surgery 1989;13(5):555-9.
1989: Mohler J L; Erozan Y S; Walsh P C; Epstein J I
Fine-needle core and aspiration biopsy. A new method for diagnosis of prostatic carcinoma.
Cancer 1989;63(9):1846-55.
1989: Alexander R B; Maguire M G; Epstein J I; Walsh P C
Pathological stage is higher in older men with clinical stage B1 adenocarcinoma of the prostate.
The Journal of urology 1989;141(4):880-2.
1989: Weber J P; Oesterling J E; Peters C A; Partin A W; Chan D W; Walsh P C
The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostatic hyperplasia.
The Journal of urology 1989;141(4):987-92.
1989: Quinlan D M; Nelson R J; Partin A W; Mostwin J L; Walsh P C
The rat as a model for the study of penile erection.
The Journal of urology 1989;141(3):656-61.
1989: Partin A W; Epstein J I; Cho K R; Gittelsohn A M; Walsh P C
Morphometric measurement of tumor volume and per cent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer.
The Journal of urology 1989;141(2):341-5.
1989: Lepor H; Kimball A W; Walsh P C
Cause-specific actuarial survival analysis: a useful method for reporting survival data in men with clinically localized carcinoma of the prostate.
The Journal of urology 1989;141(1):82-4.
1989: Walsh P C; Oesterling J E; Epstein J I; Bruzek D J; Rock R C; Chan D W
The value of prostate-specific antigen in the management of localized prostatic cancer.
Progress in clinical and biological research 1989;303():27-33.
1988: Walsh P C; Schlegel P N
Radical pelvic surgery with preservation of sexual function.
Annals of surgery 1988;208(4):391-400.
1988: Walsh P C
Nerve sparing radical prostatectomy for early stage prostate cancer.
Seminars in oncology 1988;15(4):351-8.
1988: Marshall F F; Weiskopf F; Singh A; Mark F; Leo F; Sanders R; Makofski R; Walsh P C; Smith N
A prototype device for nonimmersion shock wave lithotripsy using ultrasonography for calculus localization.
The Journal of urology 1988;140(2):249-53.
1988: Epstein J I; Oesterling J E; Walsh P C
Tumor volume versus percentage of specimen involved by tumor correlated with progression in stage A prostatic cancer.
The Journal of urology 1988;139(5):980-4.
1988: Epstein J I; Oesterling J E; Walsh P C
The volume and anatomical location of residual tumor in radical prostatectomy specimens removed for stage A1 prostate cancer.
The Journal of urology 1988;139(5):975-9.
1988: Walsh P C
The role of estrogen/androgen synergism in the pathogenesis of benign prostatic hyperplasia.
The Journal of urology 1988;139(4):826.
1988: Oesterling J E; Chan D W; Epstein J I; Kimball A W; Bruzek D J; Rock R C; Brendler C B; Walsh P C
Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy.
The Journal of urology 1988;139(4):766-72.
1988: Walsh P C
Radical retropubic prostatectomy with reduced morbidity: an anatomic approach.
NCI monographs : a publication of the National Cancer Institute 1988;(7):133-7.
1988: Lepor H; Walsh P C
Long-term results of radical prostatectomy in clinically localized prostate cancer: experience at the Johns Hopkins Hospital.
NCI monographs : a publication of the National Cancer Institute 1988;(7):117-22.
1988: Walsh P C
Preservation of sexual function in the surgical treatment of prostatic cancer--an anatomic surgical approach.
Important advances in oncology 1988;():161-70.
1987: Walsh P C
Adjuvant radiotherapy after radical prostatectomy: is it indicated?
The Journal of urology 1987;138(6):1427-8.
1987: Schlegel P N; Walsh P C
Neuroanatomical approach to radical cystoprostatectomy with preservation of sexual function.
The Journal of urology 1987;138(6):1402-6.
1987: Rock R C; Chan D W; Bruzek D; Waldron C; Oesterling J; Walsh P
Evaluation of a monoclonal immunoradiometric assay for prostate-specific antigen.
Clinical chemistry 1987;33(12):2257-61.
1987: Walsh P C
Radical prostatectomy, preservation of sexual function, cancer control. The controversy.
The Urologic clinics of North America 1987;14(4):663-73.
1987: Walsh P C; Epstein J I; Lowe F C
Potency following radical prostatectomy with wide unilateral excision of the neurovascular bundle.
The Journal of urology 1987;138(4):823-7.
1987: Chan D W; Bruzek D J; Oesterling J E; Rock R C; Walsh P C
Prostate-specific antigen as a marker for prostatic cancer: a monoclonal and a polyclonal immunoassay compared.
Clinical chemistry 1987;33(10):1916-20.
1987: Peters C A; Walsh P C
The effect of nafarelin acetate, a luteinizing-hormone-releasing hormone agonist, on benign prostatic hyperplasia.
The New England journal of medicine 1987;317(10):599-604.
1987: Walsh P C; Lepor H
The role of radical prostatectomy in the management of prostatic cancer.
Cancer 1987;60(3 Suppl):526-37.
1987: Oesterling J E; Brendler C B; Epstein J I; Kimball A W; Walsh P C
Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate.
The Journal of urology 1987;138(1):92-8.
1987: Schlegel P N; Walsh P C
Simultaneous preperitoneal hernia repair during radical pelvic surgery.
The Journal of urology 1987;137(6):1180-3.
1987: Oesterling J E; Epstein J I; Walsh P C
Long-term autopsy findings following radical prostatectomy.
Urology 1987;29(6):584-8.
1987: Lepor H; Walsh P C
The role of radical prostatectomy in the management of stage B adenocarcinoma of the prostate.
Progress in clinical and biological research 1987;243B():343-56.
1987: Barrack E R; Brendler C B; Walsh P C
Steroid receptor and biochemical profiles in prostatic cancer: correlation with response to hormonal treatment.
Progress in clinical and biological research 1987;243A():79-97.
1986: Epstein J I; Oesterling J E; Eggleston J C; Walsh P C
Frozen section detection of lymph node metastases in prostatic carcinoma: accuracy in grossly uninvolved pelvic lymphadenectomy specimens.
The Journal of urology 1986;136(6):1234-7.
1986: Oesterling J E; Epstein J I; Walsh P C
The inability of adrenal androgens to stimulate the adult human prostate: an autopsy evaluation of men with hypogonadotropic hypogonadism and panhypopituitarism.
The Journal of urology 1986;136(5):1030-4.
1986: Epstein J I; Paull G; Eggleston J C; Walsh P C
Prognosis of untreated stage A1 prostatic carcinoma: a study of 94 cases with extended followup.
The Journal of urology 1986;136(4):837-9.
1986: Hamper U M; Dahnert W F; Eggleston J C; Walsh P C; Sanders R C
Ultrasonography of prostatic carcinoma employing amplitude-enveloped (AM) and frequency-demodulated (FM) imaging: in vivo, in vitro, and pathologic correlation.
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 1986;5(10):557-62.
1986: Jarow J P; Berkovitz G D; Migeon C J; Gearhart J P; Walsh P C
Elevation of serum gonadotropins establishes the diagnosis of anorchism in prepubertal boys with bilateral cryptorchidism.
The Journal of urology 1986;136(1 Pt 2):277-9.
1986: Benson M C; Walsh P C
The application of flow cytometry to the assessment of tumor cell heterogeneity and the grading of human prostatic cancer: preliminary results.
The Journal of urology 1986;135(6):1194-8.
1986: Dähnert W F; Hamper U M; Walsh P C; Eggleston J C; Sanders R C
The echogenic focus in prostatic sonograms, with xeroradiographic and histopathologic correlation.
Radiology 1986;159(1):95-100.
1986: Walsh P C
Fine needle aspiration of the prostate--why has it taken so long to accept?
The Journal of urology 1986;135(2):334-5.
1986: Dähnert W F; Hamper U M; Eggleston J C; Walsh P C; Sanders R C
Prostatic evaluation by transrectal sonography with histopathologic correlation: the echopenic appearance of early carcinoma.
Radiology 1986;158(1):97-102.
1985: Eggleston J C; Walsh P C
Radical prostatectomy with preservation of sexual function: pathological findings in the first 100 cases.
The Journal of urology 1985;134(6):1146-8.
1985: Droller M J; Walsh P C
Intensive intravesical chemotherapy in the treatment of flat carcinoma in situ: is it safe?
The Journal of urology 1985;134(6):1115-7.
1985: Peters C A; Walsh P C
Blood transfusion and anesthetic practices in radical retropubic prostatectomy.
The Journal of urology 1985;134(1):81-3.
1985: Lepor H; Gregerman M; Crosby R; Mostofi F K; Walsh P C
Precise localization of the autonomic nerves from the pelvic plexus to the corpora cavernosa: a detailed anatomical study of the adult male pelvis.
The Journal of urology 1985;133(2):207-12.
1984: Walsh P C; Mostwin J L
Radical prostatectomy and cystoprostatectomy with preservation of potency. Results using a new nerve-sparing technique.
British journal of urology 1984;56(6):694-7.
1984: Berry S J; Coffey D S; Walsh P C; Ewing L L
The development of human benign prostatic hyperplasia with age.
The Journal of urology 1984;132(3):474-9.
1984: Marshall F F; Walsh P C
In situ management of renal tumors: renal cell carcinoma and transitional cell carcinoma.
The Journal of urology 1984;131(6):1045-9.
1984: Brendler C B; Isaacs J T; Follansbee A L; Walsh P C
The use of multiple variables to predict response to endocrine therapy in carcinoma of the prostate: a preliminary report.
The Journal of urology 1984;131(4):694-700.
1984: Walsh P C
Human benign prostatic hyperplasia: etiological considerations.
Progress in clinical and biological research 1984;145():1-25.
1983: Walsh P C; Hutchins G M; Ewing L L
Tissue content of dihydrotestosterone in human prostatic hyperplasis is not supranormal.
The Journal of clinical investigation 1983;72(5):1772-7.
1983: Droller M J; Walsh P C
Therapeutic efficacy of salvage cystectomy. Do results reflect natural history of bladder cancer?
Urology 1983;22(2):118-22.
1983: Ekman P; Barrack E R; Greene G L; Jensen E V; Walsh P C
Estrogen receptors in human prostate: evidence for multiple binding sites.
The Journal of clinical endocrinology and metabolism 1983;57(1):166-76.
1983: Kaufman S L; Kadir S; Barth K H; Smyth J W; Walsh P C; White R I
Mechanisms of recurrent varicocele after balloon occlusion or surgical ligation of the internal spermatic vein.
Radiology 1983;147(2):435-40.
1983: Brendler C B; Berry S J; Ewing L L; McCullough A R; Cochran R C; Strandberg J D; Zirkin B R; Coffey D S; Wheaton L G; Hiler M L; Bordy M J; Niswender G D; Scott W W; Walsh P C
Spontaneous benign prostatic hyperplasia in the beagle. Age-associated changes in serum hormone levels, and the morphology and secretory function of the canine prostate.
The Journal of clinical investigation 1983;71(5):1114-23.
1983: Barrack E R; Bujnovszky P; Walsh P C
Subcellular distribution of androgen receptors in human normal, benign hyperplastic, and malignant prostatic tissues: characterization of nuclear salt-resistant receptors.
Cancer research 1983;43(3):1107-16.
1983: Isaacs J T; Brendler C B; Walsh P C
Changes in the metabolism of dihydrotestosterone in the hyperplastic human prostate.
The Journal of clinical endocrinology and metabolism 1983;56(1):139-46.
1983: Walsh P C; Lepor H; Eggleston J C
Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations.
The Prostate 1983;4(5):473-85.
1982: Ekman P; Barrack E R; Walsh P C
Simultaneous measurement of progesterone and androgen receptors in human prostate: a microassay.
The Journal of clinical endocrinology and metabolism 1982;55(6):1089-99.
1982: Walsh P C; Donker P J
Impotence following radical prostatectomy: insight into etiology and prevention.
The Journal of urology 1982;128(3):492-7.
1982: Lepor H; Ross A; Walsh P C
The influence of hormonal therapy on survival of men with advanced prostatic cancer.
The Journal of urology 1982;128(2):335-40.
1982: Nyberg L M; Bias W B; Hochberg M C; Walsh P C
Identification of an inherited form of Peyronie's disease with autosomal dominant inheritance and association with Dupuytren's contracture and histocompatibility B7 cross-reacting antigens.
The Journal of urology 1982;128(1):48-51.
1982: Bias W B; Nyberg L M; Hochberg M C; Walsh P C
Peyronie's disease: a newly recognized autosomal-dominant trait.
American journal of medical genetics 1982;12(2):227-35.
1982: Goldman S M; Gatewood O M; Walsh P C; Dornhorst A; Siegelman S S
CT configuration of the enlarged adrenal gland.
Journal of computer assisted tomography 1982;6(2):276-80.
1982: Elder J S; Jewett H J; Walsh P C
Radical perineal prostatectomy for clinical stage B2 carcinoma of the prostate.
The Journal of urology 1982;127(4):704-6.
1982: Trachtenberg J; Walsh P C
Correlation of prostatic nuclear androgen receptor content with duration of response and survival following hormonal therapy in advanced prostatic cancer.
The Journal of urology 1982;127(3):466-71.
1982: Elder J S; Isaacs J T; Walsh P C
Androgenic sensitivity of the gubernaculum testis: evidence for hormonal/mechanical interactions in testicular descent.
The Journal of urology 1982;127(1):170-6.
1982: Trachtenberg J; Bujnovszky P; Walsh P C
Androgen receptor content of normal and hyperplastic human prostate.
The Journal of clinical endocrinology and metabolism 1982;54(1):17-21.
1981: Whelton P K; Harris A P; Russell R P; Walsh P C; Williams G M; Harrington D P; Walker W G
Renovascular hypertension: results of medical and surgical therapy.
The Johns Hopkins medical journal 1981;149(6):213-9.
1981: Walsh P C; White R I
Balloon occlusion of the internal spermatic vein for the treatment of varicoceles.
JAMA : the journal of the American Medical Association 1981;246(15):1701-2.
1981: Walsh P C
Randomized study of prostatic cancer.
Urology 1981;18(2):219-20.
1981: Feinstein R S; Gatewood O M; Goldman S M; Copeland B; Walsh P C; Siegelman S S
Computerized tomography in the diagnosis of retroperitoneal fibrosis.
The Journal of urology 1981;126(2):255-9.
1981: Ehrlichman R J; Kaufman S L; Siegelman S S; Trump D L; Walsh P C
Computerized tomography and lymphangiography in staging testis tumors.
The Journal of urology 1981;126(2):179-81.
1981: Fichman K R; Nyberg L M; Bujnovszky P; Brown T R; Walsh P C
The ontogeny of the androgen receptor in human foreskin.
The Journal of clinical endocrinology and metabolism 1981;52(5):919-23.
1981: White R I; Kaufman S L; Barth K H; Kadir S; Smyth J W; Walsh P C
Occlusion of varicoceles wih detachable balloons.
Radiology 1981;139(2):327-34.
1981: Cantrell B B; DeKlerk D P; Eggleston J C; Boitnott J K; Walsh P C
Pathological factors that influence prognosis in stage A prostatic cancer: the influence of extent versus grade.
The Journal of urology 1981;125(4):516-20.
1981: Trachtenberg J; Hicks L L; Walsh P C
Methods for the determination of androgen receptor content in human prostatic tissue.
Investigative urology 1981;18(5):349-54.
1981: Schmeller N T; Siegelman S S; Walsh P C
Anatomical considerations in suprahilar lymph node dissection for testicular tumors.
Urologia internationalis 1981;36(6):341-5.
1980: Howards S S; Walsh P C
Radioimmunoassay for prostatic acid phosphatase.
The Journal of urology 1980;124(5):753-4.
1980: Walsh P C
Radical prostatectomy for the treatment of localized prostatic carcinoma.
The Urologic clinics of North America 1980;7(3):583-91.
1980: Rosenshein N B; Lichter A S; Walsh P C
Cervical cancer complicated by a pelvic kidney.
The Journal of urology 1980;123(5):766-7.
1980: Murphy J B; Emmott R C; Hicks L L; Walsh P C
Estrogen receptors in the human prostate, seminal vesicle, epididymis, testis, and genital skin: a marker for estrogen-responsive tissues?
The Journal of clinical endocrinology and metabolism 1980;50(5):938-48.
1980: Trachtenberg J; Hicks L L; Walsh P C
Androgen- and estrogen-receptor content in spontaneous and experimentally induced canine prostatic hyperplasia.
The Journal of clinical investigation 1980;65(5):1051-9.
1980: Scott W W; Menon M; Walsh P C
Hormonal therapy of prostatic cancer.
Cancer 1980;45(7 Suppl):1929-36.
1980: Walsh P C; Jewett H J
Radical surgery for prostatic cancer.
Cancer 1980;45(7 Suppl):1906-11.
1980: Zerhouni E A; Siegelman S S; Walsh P C; White R I
Elevated pressure in the left renal vein in patients with varicocele: preliminary observations.
The Journal of urology 1980;123(4):512-3.
1979: Whelton P K; Harris A P; Russell R P; Walsh P C; Williams G M; Harrington D P; Walker W G
Renovascular hypertension: comparison of medical and surgical therapy.
Clinical science (London, England : 1979) 1979;57 Suppl 5():445s-447s.
1979: Walsh P C; Hensle T; Wigger H J
Ambiguous genitalia in a child.
Urology 1979;14(4):405-10.
1979: DeKlerk D P; Coffey D S; Ewing L L; McDermott I R; Reiner W G; Robinson C H; Scott W W; Strandberg J D; Talalay P; Walsh P C; Wheaton L G; Zirkin B R
Comparison of spontaneous and experimentally induced canine prostatic hyperplasia.
The Journal of clinical investigation 1979;64(3):842-9.
1979: Reiner W G; Scott W W; Eggleston J C; Walsh P C
Long-term survival after hormonal therapy for stage D prostatic cancer.
The Journal of urology 1979;122(2):183-4.
1979: Lepor H; Walsh P C
Idiopathic retroperitoneal fibrosis.
The Journal of urology 1979;122(1):1-6.
1979: Hicks L L; Walsh P C
A microassay for the measurement of androgen receptors in human prostatic tissue.
Steroids 1979;33(4):389-406.
1979: Davies T F; Walsh P C; Hodgen G D; Dufau M L; Catt K J
Characterization of the primate luteinizing hormone receptor in testis homogenates and Leydig cells.
The Journal of clinical endocrinology and metabolism 1979;48(4):680-5.
1979: Walsh P C
A new cause of male infertility.
The New England journal of medicine 1979;300(5):253-4.
1979: Reiner W G; Walsh P C
An anatomical approach to the surgical management of the dorsal vein and Santorini's plexus during radical retropubic surgery.
The Journal of urology 1979;121(2):198-200.
1979: Heston W D; Menon M; Tananis C; Walsh P C
Androgen, estrogen and progesterone receptors of the R3327H Copenhagen rat prostatic tumor.
Cancer letters 1979;6(1):45-50.
1979: Walsh P C; Hicks L L
Characterization and measurement of androgen receptors in human prostatic tissue.
Progress in clinical and biological research 1979;33():51-63.
1978: McPhee S J; Katz R D; Olson J L; Walsh P C
Clinical conferences at the Johns Hopkins Hospital. Prostatic carcinoma.
The Johns Hopkins medical journal 1978;143(6):207-11.
1978: Michigan S; Whelton P K; Walsh P C
Forgotten kidney: asynchronous bilateral ureteropelvic junction obstruction.
Urology 1978;12(5):565-6.
1978: Walsh P C; Wilson J D; Allen T D; Madden J D; Porter J C; Neaves W B; Griffin J E; Goodwin W E
Clinical and endocrinological evaluation of patients with congenital microphallus.
The Journal of urology 1978;120(1):90-5.
1978: Walsh P C; Migeon C J
The phenotypic expression of selective disorders of male sexual differentiation.
The Journal of urology 1978;119(5):627-9.
1978: Rajfer J; Eggleston J C; Sanders R C; Walsh P C
Fever and prostatic mass in a young man.
The Journal of urology 1978;119(4):555-8.
1978: Rajfer J; Mendelsohn G; Arnheim J; Jeffs R D; Walsh P C
Dysgenetic male pseudohermaphroditism.
The Journal of urology 1978;119(4):525-7.
1978: Walsh P C
The differential diagnosis of ambiguous genitalia in the newborn.
The Urologic clinics of North America 1978;5(1):213-21.
1978: Rajfer J; Walsh P C
Testicular descent. Normal and abnormal.
The Urologic clinics of North America 1978;5(1):223-35.
1978: Menon M; Tananis C E; Hicks L L; Hawkins E F; McLoughlin M G; Walsh P C
Characterization of the binding of a potent synthetic androgen, methyltrienolone, to human tissues.
The Journal of clinical investigation 1978;61(1):150-62.
1977: Sanders R C; Duffy T; Mcloughlin M G; Walsh P C
Sonography in the diagnosis of retroperitoneal fibrosis.
The Journal of urology 1977;118(6):944-6.
1977: Rajfer J; Walsh P C
Hormonal regulation of testicular descent: experimental and clinical observations.
The Journal of urology 1977;118(6):985-90.
1977: Amrhein J A; Klingensmith G J; Walsh P C; McKusick V A; Migeon C J
Partial androgen insensitivity: the Reifenstein syndrome revisited.
The New England journal of medicine 1977;297(7):350-6.
1977: Marshall F F; Walsh P C
Extrarenal manifestations of renal cell carcinoma.
The Journal of urology 1977;117(4):439-40.
1977: Menon M; Tananis C E; McLoughlin M G; Lippman M E; Walsh P C
The measurement of androgen receptors in human prostatic tissue utilizing sucrose density centrifugation and a protamine precipitation assay.
The Journal of urology 1977;117(3):309-12.
1977: Menon M; Tananis C E; McLoughlin M G; Walsh P C
Androgen receptors in human prostatic tissues: a review.
Cancer treatment reports 1977;61(2):265-71.
1977: Rajfer J; Coffey D S; Walsh P C
Effects of hormones in the newborn period on the development of the penis.
Surgical forum 1977;28():570-3.
1977: Walsh P C
The endocrinology of testicular tumors.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1977;(60):196-201.
1977: Walsh P C; Greco J M; Tananis C E; Hicks L L; McLoughlin M G; Menon M
The binding of a potent synthetic androgen--methyltrienolone (R 1881)--to cytosol preparations of human prostatic cancer.
Transactions of the American Association of Genito-Urinary Surgeons 1977;69():78-80.
1977: Rajfer J; Walsh P C
Testicular descent.
Birth defects original article series 1977;13(2):107-22.
1976: Rajfer J; Walsh P C
The incidence of intersexuality in patients with hypospadias and cryptorchidism.
The Journal of urology 1976;116(6):769-70.
1976: Clyde H R; Walsh P C; English R W
Elevated plasma testosterone and gonadotropin levels in infertile males with hyperthyroidism.
Fertility and sterility 1976;27(6):662-6.
1976: Walsh P C; Wilson J D
The induction of prostatic hypertrophy in the dog with androstanediol.
The Journal of clinical investigation 1976;57(4):1093-7.
1976: Sloan W R; Walsh P C
Familial persistent Müllerian duct syndrome.
The Journal of urology 1976;115(4):459-61.
1976: Walsh P C; Curry N; Mills R C; Siiteri P K
Plasma androgen responce to hCG stimulation in prepubertal boys with hypospadias and cryptorchidism.
The Journal of clinical endocrinology and metabolism 1976;42(1):52-9.
1976: Walsh P C; McLoughlin M G; Menon M; Tananis C
Measurement of androgen receptors in human prostatic tissue: methodological considerations.
Progress in clinical and biological research 1976;6():159-68.
1976: Walsh P C
Benign prostatic hyperplasia: etiological considerations.
Progress in clinical and biological research 1976;6():1-8.
1975: Catt K J; Dufau M L; Neaves W B; Walsh P C; Wilson J D
LH-hCG receptors and testosterone content during differentiation of the testis in the rabbit embryo.
Endocrinology 1975;97(5):1157-65.
1975: Cochran J S; Walsh P C; Porter J C; Nicholson T C; Madden J D; Peters P C
The endocrinology of human chorionic gonadotropin-secreting testicular tumors: new methods in diagnosis.
The Journal of urology 1975;114(4):549-55.
1975: Swerdloff R S; Walsh P C
Pituitary and gonadal hormones in patients with varicocele.
Fertility and sterility 1975;26(10):1006-12.
1975: Madden J D; Walsh P C; MacDonald P C; Wilson J D
Clinical and endocrinologic characterization of a patients with the syndrome of incomplete testicular feminization.
The Journal of clinical endocrinology and metabolism 1975;41(4):751-60.
1975: Walsh P C; Siiteri P K
Suppression of plasma androgens by spironolactone in castrated men with carcinoma of the prostate.
The Journal of urology 1975;114(2):254-6.
1975: Walsh P C
Physiologic basis for hormonal theapy in carcinoma of the prostate.
The Urologic clinics of North America 1975;2(1):125-40.
1974: Walsh P C; Madden J D; Harrod M J; Goldstein J L; MacDonald P C; Wilson J D
Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias.
The New England journal of medicine 1974;291(18):944-9.
1974: Nicholson T C; Walsh P C; Rotner M B
Lymphadenectomy combined with preoperative and postoperative cobalt 60 teletherapy in the management of embryonal carcinoma and teratocarcinoma of the testis.
The Journal of urology 1974;112(1):109-10.
1974: Hill D R; Crews Q E; Walsh P C
Prostate carcinoma: radiation treatment of the primary and regional lymphatics.
Cancer 1974;34(1):156-60.
1974: Henry S C; Walsh P C; Rotner M B
Choriocarcinoma of the testis.
The Journal of urology 1974;112(1):105-8.
1974: Cochran J S; Walsh P C; Porter J C; Nicholson T P; Peters P C
Clinical evaluation of human chorionic gonadotropin levels in men with testicular tumors.
Surgical forum 1974;25(0):542-3.
1973: Piconi J R; Henry S C; Walsh P C
Rapid development of carcinoma in diverticulum of the bladder. A pitfall in conservative management.
Urology 1973;2(6):676-7.
1973: Walsh P C; Swerdloff R S; Odell W D
Feedback control of FSH in the male: role of oestrogen.
Acta endocrinologica 1973;74(3):449-60.
1973: Walsh P C; Swerdloff R S
Biphasic effect of testosterone on spermatogenesis in the rat.
Investigative urology 1973;11(3):190-3.
1973: Khudr G; Walsh P C; Benirschke K
Quinacrine fluorescence of testicular tumors.
Urology 1973;2(2):162-4.
1973: Walsh P C; Swerdloff R S; Odell W D
Feedback regulation of gonadotropin secretion in men.
The Journal of urology 1973;110(1):84-9.
1973: Smith R B; Walsh P C; Goodwin W E
Cyproterone acetate in the treatment of advanced carcinoma of the prostate.
The Journal of urology 1973;110(1):106-8.
1973: Walsh P C; Kaufman J J; Smith R B; Goodwin W E
Percutaneous antegrade pyelography in hydronephrosis. Preoperative assessment.
Urology 1973;1(6):537-41.
1973: Saalfeld J; Walsh P C; Goodwin W E
Ureterovaginoplasty for vaginal atresia (unique technique in treatment): a case report with description of associated arterial anomalies and retroiliac artery ureters.
The Journal of urology 1973;109(6):1039-45.
1973: Swerdloff R S; Walsh P C
Testosterone and oestradiol suppression of LH and FSH in adult male rats: duration of castration, duration of treatment and combined treatment.
Acta endocrinologica 1973;73(1):11-21.
1973: Walsh P C; Swerdloff R S
Experimental cryptorchism: effect on serum LH and FSH in the rat.
Urological research 1973;1(1):22-6.
1973: Constantinople N L; Walsh P C
Activity of müllerian-inhibiting substance in postnatal testes.
Surgical forum 1973;24():538-9.
1972: Swerdloff R S; Walsh P C; Odell W D
Control of LH and FSH secretion in the male: Evidence that aromatization of androgens to estradiol is not required for inhibition of gonadotropin secretion.
Steroids 1972;20(1):13-22.
1972: Walsh P C; Swerdloff R S; Odell W D
Cyproterone: effect on serum gonadotropins in the male.
Endocrinology 1972;90(6):1655-9.
1972: Walsh P C; Swerdloff R S
Testosterone: effect on rat testis.
Surgical forum 1972;23(0):522-3.
1971: Walsh P C; Kaufman J J; Coulson W F; Goodwin W E
Retroperitoneal lymphadenectomy for testicular tumors.
JAMA : the journal of the American Medical Association 1971;217(3):309-12.
1971: Walsh P C; Korenman S G
Mechanism of androgenic action: effect of specific intracellular inhibitors.
The Journal of urology 1971;105(6):850-7.
1971: Swerdloff R S; Walsh P C; Jacobs H S; Odell W D
Serum LH and FSH during sexual maturation in the male rat: effect of castration and cryptorchidism.
Endocrinology 1971;88(1):120-8.
1970: Walsh P C; Gittes R F; Lecky J W
Aortography in experimental renal failure. Evaluation of contrast media toxicity.
Radiology 1970;97(1):33-7.
1970: Walsh P C; Gittes R F
Inhibition of extratesticular stimuli to prostatic growth in the castrate rat by antiandrogens.
Endocrinology 1970;87(3):624-7.
1970: Walsh P C; Swerdloff R S; Odell W D
Cryptorchism: effect on pituitary gonadotropin secretion in the rat.
Surgical forum 1970;21():530-2.
1969: Walsh P C; Gittes R F
Inhibition by antiandrogens of the prostatic growth stimulated by adrenal androgens and pituitary prolactin in castrate rats.
Surgical forum 1969;20():518-9.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Patrick Walsh

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Anatomy

Concepts & Ideas

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Patrick Walsh (preview)

All Publications